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Humanity has witnessed a huge leap in technologic progress. People have 
benefited of the improvement of life quality in all the fields, yet they become more 
exposed to new dangers as oxidative stress caused by free radicals. These latter are 
mainly originated from pollution, smoking, and stress…etc. They can lead to ageing 
and age-related illnesses [1] like Alzheimer and cardiovascular diseases. In the aim to 
overcome the detrimental effects of oxidative stress, it is recommended to use the 
antioxidants. They act with several mechanisms in scavenging the free radicals.  
In the case of the pandemic COVID 19 appeared recently in all over the world [2], 
the treatment suggested to combat the virus comprises glutathione, vitamin C and zinc 
which are among the strongest antioxidants. They contribute in supporting the 
immune function. It is also shown that vitamin C may protect lungs from the 
infections caused by the oxidative stress. Moreover, antioxidants are actually added to 
drug formulations to enhance their activities. They are even used in the anticancer 
medical protocol in the aim to boost the anticancer drugs activity. Antioxidants are 
also primordial for drugs preservation for longer durations [3].  
The class of antioxidants is vast; it is clustered according to several criteria such as, 
action mechanism and origin. The benzofurans and the flavonoids which belong to 
polyphenols [4] are known to have a high antioxidant activity. Besides, they are 
abundant in nature, so, they may be a part of our daily diet. For their crucial role, the 
benzofurans and the flavonoids are largely studied. In order to rationalize their 
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Relationship (QSAR) [5] is a powerful tool helping in evaluating the correlation 
between chemical structures and activities. It may be established within different 
methods, for instance, Gaussian processes and artificial neural networks. In 
combination with other multivariate and simulation methods, the data sets may be 
overly characterized, especially with the integration of the docking [6] and the 
ADMET in researches [7].  
In this context, our present work aims to explore two antioxidant data sets of 
benzofurans and flavonoids. Therefore, we start with a general introduction of this 
topic. Then, the core of our work is divided into four chapters; the first one concerns 
generalities about the antioxidant activity. It presents their types, sources and action 
mechanisms. Next, we highlight the different computational methods used in QSAR 
and drug-likeness studies in chapter 2. We give explanations and theories for each 
technique used in our work such as, DFT, Gaussian process and neural networks.   
The third chapter focuses on the QSAR modeling and drug-likeness screening of a set 
of fifteen benzofurans [8, 9], (This work is published in: Journal of Molecular 
Structure, 1189, pp 307- 314, 2019). The last chapter emphasizes on a QSAR study of 
some flavonoids [10, 11] by means of Gaussian process infrequently used in this 
approach, in addition to a clustering study of our data set.  
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Chapter 1. Free radicals and Antioxidants  
 
1.1 Introduction 
Life is impossible without oxygen. Its presence is fundamental for the metabolism 
of living cells. It is used to metabolizing fats, proteins, and carbohydrates to get 
energy, so it is primordial for our life, our development as well as our ability of 
adaptation. However, oxygen is a highly reactive atom; it leads to the production of 
free radical molecules particularly reactive oxygen species (ROS) which may be at the 
origin of toxicity, acidity, deterioration, and degeneration. These latter may be 
detrimental for body cells.   
As a remediation, antioxidants can interfere so as to counterbalance the oxidant 
effects and to remantain the redox equilibrium [1-3]. They can play the role of 
prophylactic agents [4]. 
This first chapter will focus on the oxidative stress and its reparation by the several 
types of antioxidants.  
1.2 Free radicals and oxidative stress 
Free radicals have unpaired electrons that make them highly reactive and 
detrimental for lipids, proteins, and DNA. Free radicals impact on cellular membranes 
by lipid peroxidation and on proteins and nucleic acids by oxidative damage. The high 
production of free radicals accompanied with their low scavenging activity leads to an 
oxidative stress [5]. 
Autooxidation can deteriorate the lipid based food; it causes a loss in the 
nutritional values, and the production of some undesired derivatives [6]. Furthermore, 
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free-radical-initiated autooxidation of cellular membrane lipids is accepted to be 
inductive of many diseases as cancer…etc [7-9]. 
Oxidative stress was defined by Haliwell and Gutteridge (1985) [10] as the defense 
incapacity of organs and cells against the aggressive free radicals derived from 
oxygen.   
Furthermore, oxidative stress is known to be an imbalanced equilibrium between 
the rates of production and elimination of free radicals (oxidants) [11].  
1.2.1 Origin of free radicals  
ROS are devising into two classes accordion to their structure. They include 
nonradical species as hydrogen peroxide (H2O2), hypochlorous acid (HOCl), singlet 
oxygen (1O2), and free radicals such as superoxide anion radical (O2
∙−), and hydroxyl 
radical (HO∙)… [12-14]. 
The free radicals half-life is about 10-9 to 10-6 s [15]. 
We can also distinguish the endogenous ROS, which are produced as natural by 
cellular metabolism (oxidative metabolism) such as the mitochondrial electron 
transport chain and NADPH oxidase activity. Besides, the extracellular ROS 
(environmental stressors) generated by UV light and other ionizing radiation, bugs, 
xenobiotic, and pollutants [16, 17]. 
 Mitochondrial respiratory chain: After the free radicals had been discovered in 
the biologic system; Harman et al. (1956) evoked for the first time, in 1956, the 
hypothesis of the damage caused by these radicals. Moreover, it was found that they 
are leading to the phenomenon of aging. 
For the majority of living beings, oxygen (O2) is crucial for the production of 
energy by the oxidative phosphorylation reaction generating ATP. This reaction is 
occurred by the electron transport chain in the internal mitochondrial membrane.  
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During a normal metabolic chain, the tetravalent reduction of oxygen to water (Figure 
1.1) creates primary ROS through many stages. Hydroxyl radical (OH∙) is considered 
as the most deleterious one. The degradation of these radicals is controlled by the 
antioxidants [18]. 
O2                    O2






+ e- + 2 H+ + e- + H+  
Figure 1.1. Mitochondrial respiratory chain [18]. 
 
Globally, the oxygen is submitted to quadruple reduction and protonation to form 
water in the cells. The characteristics of each radical are illustrated on the table 1.1.  
 
Table 1.1. ROS Characteristics [15]. 
Symbol Name Characteristics 
O2 oxygen -Stable, 








singlet oxygen -Very reactive, 
-can initiate the lipoperoxidation. 
H2O2 
 
hydrogen peroxide -Stable and diffusible, 
-feebly toxic, 
- antiseptic. 
HO∙ hydroxyl radical -Very reactive, 
-principal initiator of the lipoperoxidation, 
-alters proteins and DNA. 
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Nevertheless, there is another category of radicals called secondary radicals 
including: peroxyl radical (ROO∙), hydroperoxide (ROOH), and the alkoxyl radical 
(RO∙).   
 NADPH oxidase: The majority of cells are able to produce the superoxide 
radical (O2
∙−) throughout the membrane NADPH oxidase (NOX) activity. The 
NADPH oxidase contributes in the defensive system and in the cellular signaling in 
the phagocytic and non phagocytic cells respectively [18]. 
NADPH+ 2 O2 NADP+ + H+ + 2O2
NOX
 
We take as an e 
xample, the oral cavity which is very susceptible to the oxidative damage. 
Żukowski et al., 2018 [19] reported that the factors generating ROS in this place may 
be classified into periodontal inflammation. xenobiotics (ethanol, cigarette smoke, 
drugs), unhealthy food with high-fat and protein levels, repeated dental treatment 
using different rays and materials  (ozone, non-thermal plasma, laser light, ultraviolet 
light, fluorides, dental composites, fixed orthodontic appliances, and titanium 
fixations). 
1.2.2 Oxidative stress effect on health 
At the physiological concentrations, free radicals are primordial for several 
biological functions such as playing the role of cell signaling molecules and 
controlling cell viability, migration, and differentiation. Moreover, free radicals 
contribute in the defensive system through combating the pathological agents and 
inactivating them [20- 22]. However, an oxidative-antioxidant imbalance and an 
oxidative stress may be appeared when the levels of ROS exceed the physiological 
concentrations [23].  
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Oxidation process caused by reactive oxygen species such as O2
•_, OH•, and lipid 
peroxyl radicals ROO• can provoke an oxidative stress leading to a considerable 
damage of cellular proteins, nucleic acids, and lipids. This damage is implicated in the 
apparition of many diseases [17, 24].   
Consequently, free radicals damage can cause proteins denaturation, DNA mutation, 
and binding to unsaturated lipid membrane leading to lose of fluidity [17]. 
Our body is able to elaborate its system of protection against the oxidative stress, yet 
this system may be overwhelmed by the excess generation of free radicals [8]. 
The oxidative stress is generally considered as one of the major causes of the age-
associated diseases such as cardiovascular diseases, cancers, Parkinson’s and 
Alzheimer’s diseases…etc [2, 25]: 
 Cardiovascular diseases: Cardiovascular dysfunction has several causes 
including hypercholesterolaemia, hypertension, smoking, diabetes, poor diet, stress 
and physical inactivity. One of the main of them is the atherosclerosis. This latter is 
initiated by oxidation of human low-density lipoproteins which is mediated by ROS 
and reactive nitrogen species (RNS) [9]. 
 Cancer: In the case of cancer, ROS proceed as secondary messengers in the 
intracellular signaling cascades. This act contributes to induce and sustain the 
oncogenic phenotype of cancer cells. On the contrary, ROS can stimulate the cellular 
apoptosis and play the role of antitumorigenic species.  
A balance between ROS production and scavenging usually leads to a cellular redox 
homeostasis [26, 27]. 
 Alzheimer’s disease: The oxidative stress alters strongly the brain more than 
any other organs. That is seen when mitochondrial dysfunction, increased metal 
levels, inflammation, and β-amyloid (Aβ) peptides oxidize the neurons components 
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(lipids, proteins, and nucleic acids). ROS lead to the promoting of Aβ deposition, the 
hyperphosphorylation, and the subsequent loss of synapses and neurons in the 
development of this disease [28]. 
 Skin aging: UV radiation is made up of UVA and UVB. UVA rays are 
responsible of oxidative process, for instance, lipid peroxidation, modification of 
structural proteins and DNA damage. These effects may be blocked or repaired by 
counterbalance the oxidative stress [29]… 
1.3 Antioxidants 
1.3.1 Definition 
An antioxidant is a reducing agent, yet a reducing agent is not necessarily an 
antioxidant. Hence the antioxidant is able to neutralize an oxidizing agent [30-31]. 
Even if it is present with low concentrations, an antioxidant is defined as a 
substance which can considerably decelerate or prevent the process of oxidation by 
breaking the chain of radical reactions [10]. 
The principal roles of antioxidants can be cited as following: 
 Quenching the free radicals to end their chain reaction by donating a hydrogen 
atom or transferring them an electron. 
 Oxidation reactions are generally catalyzed by metals as iron and copper, 
hence chelating these metals may stop the free radicals generation.  
 Inactivating the free radical generating enzymes such as xanthine oxidase, 
lipoxygenase, protein kinase C, mitochondrial succinoxidase, and NADPH oxidase… 
 The body has its proper defensive system against oxidation reactions; 
nevertheless it sometimes needs to stimulate the internal antioxidant enzymes by rich 
antioxidant diet [17, 32]. 
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1.3.2 Origin 
Healthy food can supply the body with the necessary amounts of antioxidants. It 
provides them even in cheap dishes. 
Some of the origins of antioxidants are illustrated on Table 1.2. 





Germ of cereal seeds, polyunsaturated vegetables oils, eggs, 
walnat… 
Lemon, orange, cantaloup, honeydew melon, cherries, kiwi, 










Fish, meat, poultry, eggs, vegetables planted in selenium rich 
soil… 
Beef, chicken, liver, fish, tofu, spinach and other leafy 
vegetables…  
Nuts, seeds, seafood, meat and grains… 
Vegetables, rice, nuts, whole grains, sea foods, seeds, 
chocolates, as well as teas… 
Milk, green vegetables, complete bread, meat, fish… 
ß- carotene Orange and dark green fruits and vegetables. 
Polyphenols Chocolate, green tea, vinegar, grapes, berries, red onion, red 
cabbage, honey…  
1.3.3 Types 
There is a variety of criteria how to classify the antioxidants. The most frequent 
classification is based on their origin and their action mechanism. 
1.3.3.1  Classification of the antioxidants according to their origin 
a) Endogenous antioxidants     
The body is the first barrier against the oxidation processes; it relies on two 
endogenous defensive systems:  
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 Enzymatic antioxidants: The main antioxidants enzymes are: superoxide 
dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX)… 
 Non enzymatic antioxidants: They are divided into proteins and non proteins 
antioxidants (Table 1.3). 
Table 1.3.  Endogenous antioxidants [34, 41- 43]. 
Class Subclass Antioxidant Activity 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   














   
  
 
   











s Superoxide dismutase 2O2+2H
+








2GSH+H2O2                GSSG+2H2O
GPX
GSH: Reduced glutathione. 
GSSG: Oxidized glutathione. 
   
   
   
   
  
   
   
   
   
   
   
   
   
   
   




















Glutathione It protects the body against the 
xenobiotic metabolism. Also, it 
contributes in the regeneration of 
the vitamin E. 
   
   



















-These proteins are linked to 
Copper or iron; they control the 












It is considered as the most 




It is a good scavenger of singlet 
oxygen 
-Coenzyme Q -It can regenerate the vitamin E, 
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b) Exogenous antioxidants 
Table 1.4.  Exogenous antioxidants [2, 42, 44- 47]. 

























Vitamins: E, C, A…  -Vitamin E is the most 
efficient antioxidant of the 
membrane lipid peroxidation, 
-vitamin C contributes to 
regenerate the vitamin E. 
Micro-nutrients cofactors: Se, Fe, 
Cu, Mn, Zn… 
-Improve the enzymes 
catalytic activity. 
Carotenoids: Beta carotene… -Protect the lipid- rich tissues 
against oxidation, 
-have a synergistic protection 
in addition with vitamins.  
Polyphenols: flavonoids, 
polyphenolic acids… 
-Scavenge the free radicals, 
-sequestrate the antioxidant 
agents, 



















Probucol Avoids the low density 
lipoprotein oxidation. 









- Butylated hydroxyanisole  
-Prevent lipid oxidation, 
-have a synergistic activity. 




Prevents rancidity and food 
color changes caused by 
oxygen and mineral traces 




Stabilizes or inhibits the auto-
polymerization of organic 
peroxides.  
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Besides the body’s own antioxidants; the dietary can enhance the fight against the 
oxidative stress using natural or synthetic antioxidants. These molecules contribute in 
fighting oxidation processes [25] as well as they serve to preserve food from 
oxidation and make longer its use duration. Some of the exogenous antioxidants are 
illustrated on the Table 1.4.  
1.3.3.2  Classification of the antioxidants according to their Action mechanism 
a) Type I: The antioxidants of this category are capable of breaking the chain of 
free radicals reactions through donating a hydrogen atom or an electron.  
ROO+ AH                             ROOH+ A  
ROO. : Free radical, 
AH: Antioxidant, 
A. : Antioxidant radical [48, 49]. 
Consequently, the antioxidants inhibit the propagation of the oxidation chain and 
scavenge the free radicals. 
Vitamins C and A, albumin, bilirubin, and flavonoids act as chain breaking 
antioxidants [50].    
b) Type II: The antioxidants that belong to type II have a preventive action [51-
53]. They may act as following: 
- Chelators of the metals catalyzing free radicals generation (EDTA, citric 
acid…). 
- Quench the ROS (enzyme SOD…). 
- Decompose the free radical into non radical compounds (enzyme CAT…) 
[50]. 
c) Type III: Some physical parameters can avoid the oxidation in the case of 
food preservation, for instance vacuum and obscurity [54]. 
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1.4  Structure- Antioxidant activity relationship 
Even there are some contradictions concerning the structure- activity relationship 
(SAR) of the antioxidants, it is believed that the strongest factors are the number of 
hydroxyl groups and their positions, as well as the conjugaison between fractions 
[55]. This conjugaison creates a resonance effect leading to the stability of the 
antioxidant radical.  
For the flavonoids, one of the most influencing parameters is the hydroxylation on 
B- ring (Figure 1.2) due to the delocalization of the unpaired electron in the aroxyl 
radical structure. That may contribute in the stabilization of the flavonoids. In 
addition, a high radical scavenging capacity is proportionally correlated to the high 
electron-donating ability, and so to low electron-oxidation peak potentials [56].  
 
Figure 1.2. Structural features for high antioxidant capacity [17, 55, 57].  
When a flavonoid donates hydrogen from a hydroxyl group, it becomes a relatively 
stable flavonoid phenoxyl radical. Next, this latter may react with a second radical 
(RO.) to give stable quinone [17].  
Nevertheless, the presence of glycosides decreases the antioxidant capacity, 
probably because of the steric hindrance effect [58]. 
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 Similarly to the flavonoids, the effect of the number and the position of hydroxyl 
groups, as well as the extension of conjugaison is obvious on the antioxidant capacity 
of benzofurans, such as the case of arylidene [59]. It is also proved that the 
mechanism of donating hydrogen is crucial in explaining antioxidant capacity. 
Moreover, tautomerism contributes in effecting the antioxidant efficiency. It has a 
role in releasing hydrogen atoms [60]. Whereas, the presence of electron attractor, 
such as halogens, decreases the ability of free radical scavenging [59].   
1.5  Antioxidant activity measurement using DPPH method  
DPPH (2, 2-diphenyl-1-picrylhydrazyl) scavenging method is a spectrophotometric 
assay. It is based on the decolorization of the purple-colored stable radical (DPPH•). 
After has been reduced by an antioxidant, the DPPH becomes non-radical (Figure 
1.3). The maximum absorbance is at 517 nm. 
Experimentally, the strength of the antioxidant is estimated by its concentration 
able to reduce 50% of the initial quantity of DPPH. 
This test is advantageous since it is simple, quick, and useful for hydrophilic and 










DPPH (purple)                                                                 DPPHH (yellow)  
Figure 1.3. DPPH assay [62]. 
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1.6  Uses of antioxidants  
The antioxidants are largely used as additives in different fields, principally in food 
industries, as well as pharmaceutical and cosmetic products.  
 Food industries: Lipid oxidation leading to rancidity and other toxic reactions 
is one the common reasons of food deterioration. Hence, the antioxidants added with 
convenient amounts may reduce this effect. They may be natural from herbs and 
spices, for instance rosemary, thyme, pepper, and clove…Besides, synthetic 
antioxidants may be used to improve the shelf life of food, such as butylated 
hydroxytoluene and butylated hydroxyanisole [52].  
 Pharmaceutical products: The aging process accelerated by the oxidative 
stress may cause many diseases as cancer, diabetes and nervous pathologies. 
Antioxidants may delay this process by the removal of the free radicals accumulated 
in vivo and in vitro [63, 64].  
 Cosmetic products: Antioxidants in cosmetics may renforce the antioxidation 
capacity of the skin which becomes weak with aging. The most common antioxidants 
currently used are: ginkgo biloba extracts, resveratrol, α-arbutin, vitamin E, and 
polysaccharides [63]. They are delivered in different galenic forms: liposoms, 
nanoparticles, emulsions…[65]. 
Thus, adding antioxidants to these formulations has a double role. They are benefic 
to health by combating the oxidative stress. Also, they are a key preservative in the 
final products where they contribute to prevent lipid oxidation and lengthen the shelf 
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-Quenching free radicals,  
-chelating metals catalyzing the 
oxidation reaction,  
-inactivating the enzymes 
contributing in the free radicals 
generation,   
-stimulation of the endogenous 
antioxidants. 
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2.1 Introduction 
The ultimate objective of drug companies is drug discovery and development 
(Figure 2.1). It is a phase which may take many years with a lot of challenges. With 
recent progresses in bioinformatics as well as computational chemistry and biology, 
drug discovery is becoming more rational. Nowadays, many researches focus on 
experimental and theoretical aspects of this discipline.  
 
Figure 2.1. Drug discovery process [1]. 
This chapter will give a general overview on some techniques used in quantitative 
structure-activity relationships that represent a primordial key in lead discovery. 
Another tool will also be overly presented; it is drug-likeness screening where we 
expose the different rules used to determine the drug candidates.     
2.2 QSAR techniques 
Quantitative Structure Activity/Property Relationship (QSAR/QSPR) approaches 
are widely studied in chemometrics, pharmacodynamics, pharmacokinetics, and 
toxicology …etc [2]. After have been proposed for the first time by Crum-Brown and 
Fraser in 1868 [3] to study the physiological activity of molecules in function of their 
composition, QSAR studies have dramatically progressed in term of capabilities of 
















computer sciences and mathematical modeling. 
introduced the linear free energy 
approaches are used nowadays like Gaussian processes, neural networks, gene 
expression programming, project pursuit regression and local lazy regression 
The pipeline of QSAR studies start
the design of new compounds 
Structure - Activity Relationship (SAR) and the 
2.2.1 Descriptors generation
As presented on Figure 2.2, descriptors generation is a principal feature in QSAR 
modeling. The descriptors values i
the mathematical models.
and the activity. So, it is need
QSAR models. In following some computational methods largely used for descriptors
Data 
collection Optimization
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For example, Hansch and Fujita
relationship model in 1964, however, new 
s with data collection and characterization 
candidate to be more active and save on the base of the 
predictive models (Figure 2.2).
Figure 2.2. QSAR pipeline [5]. 
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calculation. In general, these parameters are divided into three categories: topological, 
electronic, as well as energetic descriptors.  
2.2.1.1 Molecular mechanics 
Molecular mechanics is founded on the force field; where the variation of the 
potential energy is correlated with the molecular geometries. In this theory, the 
molecule seen as a group of atoms in the vacuum is submitted to elastic and harmonic 
forces. And, just the nucleus is taken in consideration [6].  
The energy expression is a simple sum of energies as bond stretching, bond 
bending, torsions, electrostatic interactions, Van der Waals forces, and hydrogen 
bonding. 
The advantage of molecular mechanics is its application in modeling a large range 
of molecules even macromolecules, like proteins and segments of DNA. It is also 
useful for modeling intermolecular forces well. Nevertheless, this method is unable to 
define many chemical properties as electronic excited states [7]. 
Example:  
The MM+ force field extends the MM2 by supplying additional parameters [8] as 
the electrostatic term. The advantage of these techniques is that they perform well for 
a large range of organic molecules [7]. 
2.2.1.2 Semi-empirical Methods 
The longest step for the resolution of Hartree-Fock equation is to calculate the 
bielectronic integrations. If the base has n dimensions, it will be necessary to carry out 
n4 bielectronic integrations. To overcome this weakness, the semi-empiric techniques 
were introduced so as to simplify the calculation and treat molecules without size 
restrictions. 
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Example: Parameterization method 3 (PM3) is one of the Neglect of Diatomic 
Differential Overlap (NDDO) methods; it is commonly used in organic chemistry to 
solve the structure and reactivity problems [9].    
On average, PM3 predicts energies and bond lengths more accurately than AM1 or 
MNDO [7]. 
2.2.1.3 Quantum mechanics 
Quantum mechanics explain mathematically the correct behavior of electrons. 
They aim to study the individual atoms or molecules on the basis of the wave function 
through resolving the Schrödinger equation given as following:  
𝐻𝜓 = 𝐸𝜓                                                         (2.1) 
𝐻: the Hamiltonian operator, 
𝜓: the wave function, 
E: the energy. 
This is a probabilistic description of electrons as waves. So, it can define their 
locations as probabilities. 
In general, the Hamiltonian operator is based on the kinetic energy of the particle 
within a wave formulation as well as the energy due to Coulombic attraction or 
repulsion of particles. Nevertheless, this approach is rarely used in the current 
software. It is more dependent on the Born-Oppenheimer approximation where the 
Hamiltonian for a molecule with stationary nuclei is given as an algebric sum of the 
kinetic energy of just the electrons plus the energies of  electrons-nuclei attraction and  
the electrons repulsion. The fourth term is the repulsion energy between nuclei. 
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Example: The density functional theory (DFT) is founded on the determination of the 
energy of a molecule from the electron density instead of a wave function [7]. This 
method is used in optimizing molecules geometries, studying reactivity, and 
determining spectroscopic constants…etc. Furthermore, it can establish calculations 
in fundamental and excited states [10].  
This method is advantageous since the integrals for Coulomb repulsion concern 
only the electron density, given as a three-dimensional function [7]. 
2.2.2 Modeling methods  
2.2.2.1 Gaussian processes 
Gaussian process (GP) is a generalization of the Gaussian probability distribution, 
but for an infinitely numerous possible functions. “The formal definition of GP is that 
is a set o random variables. Any finite number of the variables has a jointly Gaussian 
distribution” [11]. In other words, “A Gaussian process generates data located 
throughout some domain such that any finite subset of the range follows a 
multivariate Gaussian distribution” [12].  
GP is a Bayesian nonparametric modeling technique [13]. It is among the techniques 
based on the kernel [11].  
In Gaussian process regression, we assume that the output y of a function f at an 
input x can be written as:  
y=f(x) + ε                                                       (2.2) 
ε: Noise term. 
ε is following a normal distribution as: ε~ N(0,𝜎   ). 
The relation between observations is expressed by the covariance function, k (x, x’) 
which is generally squared exponential:  
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𝑘(𝑥, 𝑥 ′) = 𝜎 exp
′
+ 𝜎   𝛿(𝑥, 𝑥 ′)                         (2.3) 
Where, 
x, x’: input points, 
𝜎 : a hyper-parameters called the signal variance,  
l: a hyper-parameters called the length scale,  
𝛿(𝑥, 𝑥 ′):  Kronecker delta function [12]. 
Thus, to establish a GP regression, we calculate, first, the covariance matrix K, and 
then we estimate the value of 𝑦∗ at 𝑥∗. 







 )                                           (2.4) 
 𝐾∗ = [𝑘(𝑥∗, 𝑥 ) 𝑘(𝑥∗, 𝑥 ) … 𝑘(𝑥∗, 𝑥 )]                                 (2.5) 
    𝐾∗∗ = 𝑘(𝑥∗ , 𝑥∗ )                                                (2.6) 
T: Transposition. 
Our aim is to find the probability 𝑝(𝑦∗׀y) which follows a Gaussian distribution: 
𝑦∗׀y~𝑁(𝐾∗ 𝐾 𝑦, 𝐾∗∗ − 𝐾∗ 𝐾 𝐾∗ )                                   (2.7) 
 The mean of this distribution gives the best estimation of 𝑦∗: 
𝑦∗ = 𝐾∗ 𝐾 𝑦                                                         (2.8) 
2.2.2.2 Artificial neural networks  
Artificial neural network (ANN) is an imitation of biological neural network. They 
share the same structure, processing, and learning [11].  
A biological neuron works basically as following: Synapses receive impulses, 
which are processed by the cell body (Soma). Then, the soma sends a response over 
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an axon to its synapses. Synapses are connected to glands, muscles or other neurons 
[14]. 
 
Figure 2.3. Schematic of biological neuron [15].  
ANNs are principally arranged of single units known as artificial neurons which 
are interconnected and organized into layers. Each neuron ends with an output signal 
based on its activation function [16]. 
An ANN is composed of three layers: input layer, hidden layer(s), and an output layer 
[11].  
Figure 2.4 shows a single artificial neuron. It is characterized by two parts Z and 
O. The first linear fragment is a sum of the inputs (I) multiplied by their weights (W) 
adding to a bias (B).  
Z=W1* I1+ W2* I2+ W3* I3+ B                                       (2.9) 
 
Figure 2.4. Single artificial neuron [14]. 
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Whereas the output O is computed by means of a nonlinear function known as the 
activation function α: 
O= α (Z)                                                               (2.10) 
There are some activation function widely used in ANN modeling, for instance 
sigmoid and tanh activation function.   
 Sigmoid (logistic) function: 
𝛼 (𝑍) =
 
                                                            (2.11) 
 tanh activation function: 
𝛼 (𝑍) =  −  1                                                  (2.12) 
The selection of the suitable activation function is based on giving the best results, 
in addition to others criterions as interval where it is well-behaved (not saturated) 
[14]. 
Instead of fitting data to an equation, neural networks engender hidden models of 
the relations between inputs and outputs. They are capable to model nonlinear 
systems, however they have the limitation of overfitting the data [2].  
NNs can be distinguished on the base of the direction of excitation propagation within 
the network as Feed– forward and Recurrent [16]. 
Multi-layer perceptron and Radial-Basis Function are the two ANNs mainly used 
in modeling; both are feed-forward networks in which the information has one 
direction from the input to the output: 
Input descriptors      Processing     Output response 
The first method is based on a leyered network of interconnected perceptrons. The 
importance of their inputs is given by their weights which are adjusted in training a 
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single perceptron. To fulfill a good model, some parameters must be optimized, for 
instance the number of layers and neurons as well as the neuron transfer function.  
Whereas, the radial-basis function neural networks has the following structure: 
input layer, a single hidden layer and an output layer. Here, the output in the hidden 
layer is not calculated as the product of the weights by their input values. Each hidden 
layer neuron is defined by its center and it utilizes a radial basis function as a 
nonlinear transfer function. The Gaussian function is classically used where the 
adjusted parameters in the training step are the mean and the width [2, 17]. 
One of the simplest methods used in ANN is Gauss Newton algorithm. It is an 
approach in solving nonlinear least squares problems. It is a generalization of 
Newton's method, for multiple dimensions. 
x = x −
 ( )
′( )
                                                     (2.13) 
x = x −
′( )
′′( )
                                                     (2.14) 
-x: independent variable, 
-f (x): objective function, 
-f’(x): f(x) derivative, 
-f’’(x): f(x) second derivative. 
In the case of Gauss Newton method, the objective function is the sum squares of 
error (SSE) which must be minimized.  
So, the new objective function is: 
𝑓(𝑥) =  ∑ (𝑟 (𝑥))                                              (2.15) 
-r (x) is the residual function; it is defined as: 
r (x) = ɸ(x) −  y ,   i = 1, 2, … m                                (2.16) 
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-ɸ (x) is the proposed function and yi is the observation data.  
The gradient ∇f (x) and the Hessian ∇ f (x) of f (x) can be expressed in terms of the 
Jacobian as following: 
 ∇ f(x) = J(x) ∗ r(x)                                          (2.17) 
∇  𝑓(𝑥) = 𝐽(𝑥) ∗ 𝐽(𝑥) +  ∑ 𝑟 (𝑥) ∗  ∇  𝑟 (𝑥)                            (2.18) 
-J(x) T is the transpose of the Jacobian matrix. 
Thus, the needed steps to generalize Newton’s method for multiple dimensions are: 
 Replace f ’ (x) (Equation 2.14) with the gradient ∇f (x).  
 Replace f ’’(x) (Equation 2.14) with the Hessian ∇ f (x) [18, 19].   
2.2.2.3 Statistical analysis 
To process to a QSAR study, a collection of experimental data must be firstly 
done. Then, this data is splited into training set (model construction) and test set 
(external validation) [20]. When the model is established, some statistical parameters 
must be evaluated to validate the model, for instance: 
- Squared correlation coefficient for the training set (R ): 
R = 1 −  
∑ ( )
∑ ( )
                                     (2.19) 
-Squared correlation coefficient for the test set [20]: 
R = 1 −  
∑(  )
∑(   )
                                      (2.20) 
- Average relative error (ARE) [21]: 
ARE = 1 −  
∑ | |/| |
                                    (2.21) 
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-𝑦  is the desired output, 
-𝑦  is the predicted value by model, 
-𝑦 is the mean of dependant variables (training set), 
-N is the number of the molecules in the data set. 
2.2.3 Multivariate techniques 
2.2.3.1 Principal component analysis 
The Principal Component Analysis (PCA) is a statistical test used in the aim to 
reduce the number of the original variables. It serves to represent a variation present 
in a data set [22]. The PCA is principally based on finding the eigenvalues and the 
eigenvectors of the covariance matrix, as well as on maximizing the variance of the 
linear combinations between the different variables of a data set [23]. The number of 
the PCs is estimated according to different criterions, such as: 
- Select the PCs that represent 80% or 90% of the variation in the data [24]. 
- Preserve just the PCs whose variances exceed 1. It is Kaiser’s rule [25]. 
- Take the elbow point in the scree plot as the number of PCs [26]. 
2.2.3.2 Hierarchical clustering 
Hierarchical Cluster Analysis aids in simplifying the data by focusing on its 
clusters and patterns [26]. It collects the samples into nested groups [27] on the base 
of similarity between them [26]. 
2.3 Drug-likeness screening 
 The main objective of this study is to evaluate the oral bioavailability of the data 
set because in vivo, the physicochemical properties of a drug affect powerfully its 
pharmacokinetic parameters.  
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According to the rule of Lipinski [28], a good absorption is attained if: 
-the molecular weight is under 500 Da, 
-the log P is under 5, 
-there are less than 5 H-bond donors, 
-there are less than 10 H-bond acceptors. 
Veber [29] suggested that a reduced molecular flexibility, as expressed by the 
number of rotatable bonds (RB), and a low polar surface area (TPSA) may permit to 
predict a good drug oral bioavailability. He proposed that a high probability of good 
oral bioavailability is achieved if: 
-the polar surface area is equal to or less than 140 Å2, 
-there are 10 or fewer rotatable bonds. 
A drug discovery chain is not only based on the optimization of physicochemical 
parameters, yet it requires evaluating other parameters related to both of toxicity and 
bioavailability defined as lipophilic efficiency indices: ligand lipophilic efficiency 
(LipE), ligand efficiency (LE) and ligand-efficiency dependent lipophilicity (LELP) 
[30]. These factors may contribute significantly to overly estimating the drugs quality 
at different stages of discovery [31]. LipE is a combination between activity and 
lipophilicity. It explicates the effect of lipophilicity in binding to a given target. It is 
also shown that a good, in vivo, performance can be reached when potency increases 
without increasing logP [32]. 
It is suggested to target a LipE in a range of 5–7 or even higher [33]. 





LE is dependant particularly 
with a drug target. Ligand efficiency metrics 
optimization of fragments, hits, and leads. 
 
NH  is the number of heavy atoms.
LELP is correlated with both size and lipophilicity 




stages, such as computational chemistry, mathematical modeling and bioinformatics
Our preliminary study concerns tow antioxidant sets since these latter are recently 
recommended in pharmaceutical, 
followed the procedure indicated on the Figure 2.5.
Figure 2.5. 
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on sizes of small molecules interfering
are primordial for the selection and 
LE is defined as follows: 
LE=1.4* pIC50/NH
                                                             
 
[34]. The optimal LELP scores 
 
LELP= logP/ LE                                          
 backgrounds in large scientific fields even in its first 
cosmetic and food products [3]. Hence, 
Preliminary QSAR and Drug-Likeness study.
Calculation of the 
physico-chemical and 
quantum descriptors
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There is a growing consensus among scientists that a combination of antioxidants, 
rather than single entities, may be more effective over the long term. Antioxidants 
may be of great benefit in improving the quality of life by preventing or postponing 
the onset of degenerative diseases [1]. They are capable of stabilizing or deactivating 
free radicals before they attack cells. Antioxidants are critical for maintaining optimal 
cellular and systemic health and well-being [2]. 
Among compounds that show an antioxidant activity, furan [3] and benzofuran 
(Figure 3.1) derivatives. They are heterocyclic organic compounds. These derivatives 
exhibit also high potentialities for use as pharmacological agents. Indeed, these ring 
systems have emerged as powerful scaffolds for many biological evaluations and play 
an important role in the design and discovery of new physiological/pharmacologically 
active molecules. 
 
Figure 3.1. 3D conformations of furan and benzofurans. 
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This chapter [4] aims to derive a quantitative structure- antioxidant relationship 
model from a data set of fifteen synthetic furan derivatives [3] (Table 3.1) using 
artificial neural network (ANN) method on JMP 8.0.2 [5]. In the majority of studies, 
ANNs are used with large sets. We tried here, to take benefit of this technique in this 
case with just fifteen molecules. Then, Lipinski and Veber rules, and lipophilicity 
indices are applied to identify “drug-like” compounds. 
3.2  Computational details 
3.2.1 Furan geometry 
We started our investigations by optimizing furan geometry using molecular 
mechanics, with MM+ force-field, at a gradient of 0.01 kcal/ (Å.mol) [6]. Next, the 
geometry of furan was reoptimized using DFT/B3LYP, MP2 and CCSD with 6-31G 
(d,p) and cc-pVDZ basis set by Gaussian 09 program package [7] in order to select 
the most reliable predictive method comparatively to experiment. Also, 2D and 3D 
molecular electrostatic potential surface maps (2D MESP/ 3D MESP) are explored. 
3.2.2 Calculation of molecular descriptors 
Firstly, the geometries of furan derivatives were optimized by molecular 
mechanics, with MM+ force-field. Then, the QSAR properties module from Hyper 
Chem 8.08 was used to calculate: molar weight (MW), surface area (S), volume (V), 
refractivity (R), polarizability (P), octanol-water partition coefficient (log P) and 
hydration energy (HE). 
In the next step, quantum computation of the highest occupied molecular orbital 
energy (EHOMO) and lowest unoccupied molecular orbital energy (ELUMO) were 
determined using Gaussian 09 at the density functional theory level (DFT) using 
Becke’s three-parameter Lee- Yang- Parr (B3LYP),with 6-31G (d,p) basis set.  
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Finally, MarvinSketch 17.1.2 Software [8] was employed to compute: hydrogen 
bond donors (HD), hydrogen bond acceptors (HA), number of rotatable bonds (RB) 
and polar surface area (TPSA). 
3.2.3 Data set 
The studied furan derivatives and their corresponding antioxidant activity using 1, 
1- diphenyl-2-picrylhydrazyl (DPPH) were compiled from the literature (Table 3.1). 
 
 Table 3.1. Chemical structures of the molecules under study. 
N Structure  IC50 N Structure  IC50 N Structure  IC50 
1 18.5 2 
 












7.8 9 12.8 
10 
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All the studied molecules showed a free radical scavenging activity with IC50 
values ranged between 7.8 ±1.6 and 33.8 ±2.8 µM [3]. 2D structures of furan 
derivatives were constructed using the Molinspiration Database [9]. 
3.3  Results and discussion 
3.3.1 Equilibrium geometry of furan 
The most efficient theoretical method may be selected by comparison with 
experimental results. A good agreement can be observed between different predicted 
geometries (bond lengths, valence angles) and experimental data (Table 3.2), mainly 
for DFT/B3LYP at the basis 6-31G (d,p). 
The theoretical dihedral angle values calculated by different methods are either 0° 
or 180°, which explain that the geometry of furans is plane. From that, the 
DFT/B3LYP method is found to be more appropriate for further study on furan 
derivatives, in other parts of this work. 




DFT/B3LYP MP2 CCSD 





O1-C2 1.3621 1.3641 1.3635 1.3656 1.3633 1.3673 1.3654 
C2-C3 1.3609 1.3605 1.3643 1.3662 1.3779 1.3580 1.3689 
C3-C4 1.4309 1.4356 1.4381 1.4273 1.4365 1.4403 1.4502 
C2-H6 1.0750 1.0787 1.0857 1.0752 1.0877 1.0752 1.0887 




O1-C2-C3 110.68 110.53 110.59 110.50 110.78 110.83 111.12 
C2-C3-C4 106.50 106.09 105.99 106.20 105.83 106.00 105.63 
C2-O1-C5 106.55 106.77 106.82 106.60 106.77 106.35 106.49 
O1-C2-H6 115.92 115.78 115.72 115.67 115.77 115.72 115.80 
C2-C3-H7 127.95 126.54 126.55 126.21 126.30 126.54 126.58 
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Figure 3.2 shows the 3D molecular electrostatic potential surface maps (3D MESP) 
of furan and of benzofuran. MESP allows understanding various physical and 
chemical phenomena such as molecular reactivity behavior, intermolecular 
interactions, molecular recognition, electrophilic reactions, substituent effects and the 
interactions induced by the reagents, for example between a drug and its cellular 
receptor [11]. 
As can be seen, furan and benzofuran present negative electrostatic potentials (red 
zone) around the oxygen atom due to its high electronegativity. An orange region can 
be observed around the carbon atoms of the five-ring of furan and the benzene ring of 
benzofuran. Thus, these parts may be subject to electrophilic attacks. We can see also 
positive electrostatic potentials (blue zone) around the atoms of hydrogens, which 
explain that these atomic sites are susceptible for nucleophilic attacks. In sum, furan 
and benzofuran exhibit common characteristics, which may be helpful for a 
qualitative understanding of the electrostatic interactions that may take place between 
reagents or enzyme active sites and the benzofuran derivatives under study. 
 
 
Figure 3.2. 3D MESP for furan (left) and for benzofuran (right). The results are 
shown by color, from red (most negative) to blue (most positive). 
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3.3.2 Vibrational analysis  
Accurate calculations of anharmonic frequencies of molecular systems allow 
correct identification of molecules through the assignment of their experimental 
RAMAN, IR or Far-IR spectra. Such computations are also needed to establish the 
reliability of the derivatives of the potentials, i.e. force fields, in semi empirical 
approaches. 
Obviously, this is crucial for accurate predictions of thermal contributions to 
enthalpies and entropies and of the reactive properties of these compounds using such 
methods. Here, we used second order perturbation theory (VPT2) approach as 
implemented in Gaussian and MOLPRO [12] to evaluate the anharmonic vibrational 
frequencies of isolated furan and benzofuran. These data were calculated by means of 
B3LYP/6-31 G (d,p). The results are listed in Table 3. 3, where they are compared to 
the respective FT-IR of experimental data.  
 
Table 3.3. Anharmonic vibrational frequencies (in cm-1) of furan [13] and of 
benzofuran [14] as computed using B3LYP/6- 31 G (d,p).  
Furan Benzofuran 
Mode Sym. B3LYP/6-31 (d,p) Exp.  Mode Sym. B3LYP/6-31 (d,p) Exp.  
1 a1 3165 3169 1 a’ 3165 3158 
2 a1 3143 3140 2 a’ 3126 3124 
3 a1 1494 1491 3 a’ 3085 3094 
4 a1 1392 1385 4 a’ 3057 3077 
5 a1 1150 1140 5 a’ 3065 3067 
6 a1 1075 1067 6 a’ 3029 3047 
7 a1 1005 995 7 a’ 1631 1617 
8 a1 874 870 8 a’ 1601 1595 
9 a2 865 864 9 a’ 1558 1543 
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10 a2 713 722 10 a’ 1487 1478 
11 a2 606 600 11 a’ 1461 1457 
12 b1 3156 3161 12 a’ 1373 1346 
13 b1 3133 3130 13 a’ 1344 1329 
14 b1 1577 1558 14 a’ 1274 1264 
15 b1 1270 1267 15 a’ 1260 1253 
16 b1 1181 1181 16 a’ 1181 1180 
17 b1 1048 1043 17 a’ 1164 1161 
18 b1 878 873 18 a’ 1138 1131 
19 b2 827 838 19 a’ 1112 1107 
20 b2 747 745 20 a’ 1044 1036 
21 b2 612 603 21 a’ 1019 1007 
    22 a’ 902 900 
    23 a’ 855 855 
    24 a’ 770 768 
    25 a’ 614 612 
    26 a’ 544 539 
    27 a’ 404 400 
    28 a’’ 966 970 
    29 a’’ 928 929 
    30 a’’ 861 861 
    31 a’’ 848 848 
    32 a’’ 770 763 
    33 a’’ 752 746 
    34 a’’ 737 732 
    35 a’’ 590 584 
    36 a’’ 576 569 
    37 a’’ 425 418 
    38 a’’ 251 246 
    39 a’’ 218 211 
 
The benzofuran is a planar asymmetric rotor with Cs symmetry. The vibrations 
separate into 27 a' (in-plane) and 12 a’’ (out-of plane) fundamentals [15]. Furan is 
also a planar, near oblate symmetric top rotor. It possesses 8 a1, 3 a2, 7 b1, and 3 b2 
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vibrations [16]. In brief, the comparison of the B3LYP/6-31G (d,p) computed and 
measured fundamentals for furan and benzofurans shows differences of less than 10 
cm-1 between both sets of data. Again, this confirms the good performance of 
B3LYP/6-31G (d,p) chosen theoretical level for the derivation of properties of larger 
benzofuran derivatives. 
3.3.3 Data set for analysis 
In this work, 9 descriptors were chosen to describe the structure of the furan 
derivatives. Table 3.4 shows the values of the calculated descriptors used in order to 
establish the quantitative structure- antioxidant activity relatioship.   
QSAR was carried out on a series of 15 furan derivatives, the data set was 
randomly divided into two sets: a training set (12 compounds) and a testing set (3 
compounds: 6, 12 and 15) at a ratio of 80:20.   






















1 242.23 419.57 685.41 74.61 25.35 -2.44 -23.21 -0.238 0.025 18.5 
2 321.13 440.83 732.74 82.15 27.97 -2.39 -22.50 -0.240 0.008 20.6 
3 305.13 433.63 711.92 80.54 27.33 -1.36 -16.04 -0.236 0.012 33.8 
4 321.13 439.52 729.18 82.15 27.97 -2.39 -20.06 -0.235 0.013 18.0 
5 337.13 458.90 765.50 83.75 28.61 -3.41 -27.98 -0.254 0.015 14.6 
6* 321.13 447.86 741.16 82.15 27.97 -2.39 -22.68 -0.250 0.018 18.4 
7 416.02 474.28 802.32 91.29 31.23 -3.36 -25.56 -0.257 0.004 19.4 
8 400.02 471.11 790.38 89.68 30.60 -2.33 -22.03 -0.258 0.005 7.80 
9 258.23 426.19 703.13 76.22 25.98 -3.46 -28.55 -0.237 0.023 12.8 
10 242.23 418.17 682.36 74.61 25.35 -2.44     -22.56 -0.234 0.026 10.8 
11 321.13 450.12 745.24 82.15 27.97 -2.39     -22.53 -0.251 0.017 28.6 
12* 340.33 569.21 958.60 100.37 35.05 -2.27     -22.81 -0.237 0.017 16.8 
13 340.33 582.08 965.45 100.37 35.05 -2.27    -22.70 -0.239 0.017 25.4 
14 356.33 590.10 984.78 101.98 35.69 -3.29    -28.71 -0.240 0.018 11.7 
15* 340.33 542.93 941.88 100.37 35.05 -2.27    -22.09 -0.241 0.016 26.2 
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3.3.4 QSAR study 
ANN contained 6 inputs corresponding to the 6 descriptors selected from the 
correlation matrix, 2 hidden neurons, and 1 output neuron which is the IC50 (Figure 
3.3). The number of artificial neurons in the hidden layer was adjusted experimentally 
[17], two neurons in the hidden layer permitted to attain the best correlation between 
experimental and predicted data.  
The ANN was trained using Gauss Newton method. 
 
Figure 3.3. Structure of ANN. 
A good correlation of experimental and predicted IC50 calculated by ANN is 
shown in Figure 3.4., and illustrated by R2 and ARE values calculated as given by 
equations 2.19 and 2.21 (R2=0.99 and ARE= 0.99).So, Even for just 12 molecules, the 
ANN model established a good internal correlation.   
 
Figure 3.4. Correlation of experimental and predicted IC50 as calculated by ANN. 
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It is known that the test set must comprise at least five samples to consider the 
prediction statistics as reliable [18]. In spite of the small number of the test set in our 
case with just three compounds, we calculate the external correlation coefficient 
(R2pred) and AREtest according to the equations 2.20 and 2.21 respectively. That may 
be considered as only a preliminary prediction for testing new molecules. R2pred equals 
about 0.6 which is the acceptable inferior limit in external validation [19] and AREtest 
is 0.84.    
3.3.5 Drug-likeness screening 
Table 3.5 presents the drug-likeness parameters and lipophilicity indices of the 
benzofuran derivatives under investigation. We give also the criteria to satisfy the 
lipophilicity indices and the Lipinski and Veber rules. As can be seen there, all 
compounds satisfy the rules, except compounds 5, 7 and 14 which show a slight out 
of range LELP (<-10) [20]. This table shows also that these compounds have 
molecular weights of less than 500 Da. Moreover, Table 3.5 gives the values of log P, 
which is a parameter used to estimate molecular hydrophobicity. For all studied 
compounds, log P is less than zero, so these molecules possess high water solubility 
and, in principle, poor membrane permeation capacity, which may be partly remedied 
by the small molecular weight. Hydrogen bonds increase solubility in water and must 
be broken for the compound to permeate into and through the lipid bilayer membrane. 
Thus, an increasing number of hydrogen bonds reduces partitioning from the aqueous 
phase into the lipid bilayer membrane for permeation by passive diffusion [21].  
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Table 3.5. Drug-likeness parameters and lipophilicity indices of furan derivatives. 
Comp. 
Lipinski rules Veber rules Lipophilicity indices 
MW (amu) logP HD HA TPSA (Å2) RB  LipE LELP 
˂500 ˂5 ˂5 ˂10 ˂140 ˂10 >5 -10 < LELP < 10 
1 242.23 -2.44 3 3 73.82 1 7.17 -6.63 
2 321.13 -2.39 3 3 73.82 1 7.08 -6.92 
3 305.13 -1.36 2 2 53.6 1 5.83 -3.91 
4 321.13 -2.39 3 3 73.82 1 7.13 -6.84 
5 337.13 -3.41 4 4 94.05 1 8.24 -10.07 
6 321.13 -2.39 3 3 73.82 1 7.12 -6.85 
7 416.02 -3.36 4 4 94.05 1 8.07 -10.70 
8 400.02 -2.33 3 3 73.82 1 7.44 -6.52 
9 258.23 -3.46 4 4 94.05 1 8.35 -9.60 
10 242.23 -2.44 3 3 73.82 1 7.41 -6.32 
11 321.13 -2.39 3 3 73.82 1 6.93 -7.14 
12 340.33 -2.27 3 4 100.13 5 7.04 -8.49 
13 340.33 -2.27 3 4 100.13 5 6.86 -8.82 
14 356.33 -3.29 4 5 120.36 5 8.22 -12.39 
15 340.33 -2.27 3 4 100.13 5 6.85 -8.85 
We see that all the screened molecules have a number of hydrogen bonds in the 
appropriate interval of Lipinski. In addition, all benzofuran derivatives show TPSA 
values in the range of 53-120 Å2, which permit them to correlate very well with the 
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human intestinal absorption, Caco-2 monolayer's permeability, and blood-brain 
barrier penetration [22]. We can note also that compounds 12, 13, 14 and 15 are likely 
to be the most flexible with a number of rotatable bonds of 5. In the studied set, LipE 
takes values between 5.83 and 8.35. 
Thus, this set would have a high quality as lead compounds, provided that LELP is 
situated in the suggested range -10 < LELP <10 to guarantee that molecules reach 
both size and lipophilicity criteria, which is the case for all the studied compounds 
except three molecules (5, 7 and 14) having LELP inferior than the minimum limit (-
10.07, -10.70, -12.39). 
In general, according to the results listed in Table 3.5, we can estimate that all 
benzofuran derivatives satisfy the Lipinski and Veber rules, so they would not have 
problems with oral bioavailability. 80% of compounds reach an LELP in the 
suggested range -10 < LELP <10. 
3.4  Conclusion 
A QSAR study was performed on 15 benzofuran derivatives. QSAR models were 
obtained using artificial neural network technique. ANN gave a good agreement with 
experimental values even for our small data set.  Calculation of molar weight, 
octanol-water partition coefficient, number of hydrogen bond donors and hydrogen 
bond acceptors revealed that all studied molecules obey the Lipinski’s rule of five. 
These molecules satisfy also Veber rules with RB˂10 and TPSA ˂140.  
Depending on LELP calculated values, all studied set expect three compounds (5, 
7 and 14) could have promising results in the clinic. 
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Chapter 4: Quantitative structure- antioxidant activity relationship study 
for flavonoids set 
 
4.1 Introduction 
Cultivars and chemical pesticides are two potential ways of combating plant 
pathogens. However, plants can develop their own defense system so as to resist to 
biotic and abiotic stresses through the synthesis of a set of secondary metabolites as 
the flavonoids [1]. The structure of this category is based on a flavan nucleus [2]. The 
flavonoids are classified according to the pyran ring oxidation and saturation [2, 3] 
(Figure 4.1). This kind of components exists largely in some foods such as tea, fruits, 
cocoa, coffee, nuts and vegetables [4]. Honey is also known by its high amounts of 
flavonoid glycosides [5].   
The flavonoids find their applications in various medical fields. They are used as 
antioxidant [6], antitrypanosomal, antileishmanial [7], anti-inflammatory [8], 
anticancer [9], as well as antiaging compounds [10]…Since oxidative stresses are 
strongly related to several diseases [11], the majority of researches emphasize on the 
flavonoids antioxidant activity and its effect on human health [12]. 
This part aims to elaborate a statistical study of flavonoids set using principal 
component analysis and hierarchical clustering. The quantitative structure-antioxidant 
activity relationship was also carried out by means of Gaussian process. The 
antioxidant activities of the studied set were obtained from literature; they are 
measured by the DPPH radical scavenging method [13, 14].  
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Isoflavones Chalcones Anthocyanidins 
Figure 4.1. Principal flavonoids sub-classes [2, 3]. 
4.2 Descriptors calculation 
Firstly, the molecular structures of the data set were optimized by the molecular 
mechanics force field (MM+), and then these geometries were reoptimized by means 
of the semi-empirical method PM3 in HyperChem 8.0.8 software [15]. Exploring this 
latter, the following molecular descriptors were computed: molar weight, volume, 
polarizability, octanol-water partition coefficient, hydration energy, as well as the heat 
of formation (HF). 
Secondly, a comparative estimation of the bonds length and the angles of the 
quercetin, taken as an analogue of the data set, was done in order to scrutinize the 
goodness of the quantum technique that serves in the electronic descriptors 
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generation. To reach this objective, tow techniques were used: DFT/B3LYP (6-31G) 
and HF (6-31G). 
To determine the optimized level of the highest occupied molecular orbital energy, 
the lowest unoccupied molecular orbital energy and the dipole moment (DM) of the 
data set, we have used the Gaussian 09 program [16]. 
Finally, MarvinSketch [17] served to calculate: hydrogen bond donors, hydrogen 
bond acceptors, number of rotatable bonds and topological polar surface area. 
The chemical structures of the data set under study are represented on Table 4.1. 
They were obtained from the database molinspiration [18]. 
Table 4.1. Chemical structures and experimental activity of the data set [13, 14]. 
Molecule pIC50 Molecule pIC50 Molecule pIC50 
3.676 3.536 3.524 
1 2 3
4.676 4.810 5.051 
4 5 6
4.385 4.955 5.161 
7 8 9 
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4.932 4.932 5.056 
10 11 12
3.192 3.577 3.129 
13 14 15
3.274 3 3.213 
16 17 18
3.507 3.726 3.562 
19 20 21
3.964 4.795 4.589 
22 23 24 
4.219 4.909 4.157 
25 26 27
4.174 4.748 4.687 
28 29 30 
  
 
4.790    
31 
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4.3 Results and discussion 
The aim of our work was to perform an objective statistical analysis based on the 
methods PCA, HC and GP. Calculations were performed on JMP 8.0.2 [19]. We 
opted for different steps to accomplish this task as following: 
4.3.1 Descriptors generation 
The quercetin (Figure 4.2) was considered as a reference to optimize the electronic 
structure computations because it is the most common flavonoid and it is already used 
in pharmaceutical and cosmetic formulations. 
 
Figure 4.2. Quercetin structure. 
According to table 4.2, we observe that DFT at the level B3LYP/6-31G shows a 
good performance with experimental data relatively to HF/6-31G method. So, it will 
be used for the calculation of the quantum descriptors: EHOMO, ELUMO, and DM.  
The next table 4.3 collects the values of the descriptors calculated for the dataset. 
We observe that the range of masse is large; it is between 242 and 800 amu. That can 
be explained by the presence of glycosides in some derivatives. This also alters the 
topological parameters as V and Pol.  
All the values of log P are inferior to zero since the derivatives are hydrophilic due 
to the presence of OH groups. Moreover, we can estimate that the absolute values of 
HE are proportional to HD; they both quantify solubility in water.  
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Table 4.2. Bond lengths (in Å) and valence angles (in degree, °) of quercetin [20]. 
Bond length Exp. DFT B3LYP HF Angle Exp. DFT B3LYP HF 
(6-31G) (6-31G) (6-31G) (6-31G) 
(1-2) 1.36 1.40 1.38 (1-2-3) 121.26 118.17 118.21 
(1-6) 1.37 1.39 1.36 (1-2-11) 110.97 112.54 112.13 
(2-3) 1.36 1.37 1.34 (3-2-11) 127.75 129.29 129.66 
(2-11) 1.48 1.46 1.46 (2-3-18) 122.25 122.86 122.38 
(3-4) 1.45 1.44 1.45 (4-3-18) 117.34 114.93 115.60 
(3-18) 1.35 1.38 1.37 (3-4-5) 116.79 117.68 117.28 
(4-5) 1.42 1.43 1.44 (5-4-17) 122.82 123.79 123.64 
(4-17) 1.27 1.29 1.25 (4-5-10) 122.83 121.99 122.76 
(5-6) 1.39 1.41 1.40 (6-5-10) 116.96 118.43 118.12 
(5-10) 1.42 1.42 1.41 (1-6-7) 116.79 117.82 117.96 
(6-7) 1.40 1.39 1.38 (5-6-7) 122.79 122.44 122.70 
(7-8) 1.39 1.40 1.39 (6-7-8) 117.08 117.53 117.47 
(7-23) 1.02 1.68 1.07 (6-7-8) 117.08 117.53 117.47 
(8-9) 1.40 1.40 1.39 (8-7-23) 122.71 120.79 120.92 
(8-20) 1.36 1.38 1.36 (7-8-20) 117.66 116.07 116.36 
(9-10) 1.36 1.39 1.38 (9-8-20) 119.84 121.70 121.53 
(9-24) 1.01 1.08 1.07 (8-9-24) 120.44 121.82 121.88 
(10-19) 1.38 1.36 1.35 (5-10-9) 122.14 120.03 120.26 
(11-12) 1.39 1.41 1.40 (5-10-19) 118.45 120.42 121.67 
(11-16) 1.40 1.42 1.40 (9-10-19) 119.37 119.55 118.07 
(12-13) 1.39 1.40 1.39 (2-11-12) 121.34 121.81 122.19 
(12-25) 1.00 1.08 1.07 (2-11-16) 119.34 119.38 118.97 
(13-14) 1.39 1.39 1.38 (11-12-13) 121.02 120.54 120.42 
(13-26) 1.01 1.08 1.07 (11-12-25) 119.35 119.53 119.98 
(14-15) 1.38 1.41 1.39 (13-12-25) 119.62 119.93 119.60 
(14-22) 1.40 1.38 1.36 (12-13-14) 118.84 120.30 120.31 
(15-16) 1.40 1.38 0.37 (15-14-22) 118.33 120.24 120.68 
(15-21) 1.37 1.40 0.38 (14-15-21) 118.52 113.88 114.66 
(16-27) 1.01 1.08 1.07 (16-15-21) 121.40 125.01 124.37 
(18-28) 0.91 0.99 0.96 (3-18-28) 110.29 106.28 110.96 
(19-29) 0.95 1.00 0.96 (10-19-29) 101.93 109.35 113.86 
(20-30) 0.91 0.98 0.95 (8-20-30) 113.42 112.13 115.44 
(21-31) 0.99 0.97 0.95 (15-21-31) 112.59 112.83 115.54 
(22-32) 0.98 0.98 0.95 (14-22-32) 101.87 109.68 113.10 
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Table  4.3. Values of molecular descriptors used in the statistical analysis: (V, Å3), 
(HE, kcal/mol), (log P), (P, Å3), (MW, amu), (HF, kcal/mol), (EHOMO, eV), 
(ELUMO, eV), (DM, Debye), (RB), (HD), (HA), and (TPSA, Å2). 
N V  HE log P Pol MW HF EHOMO ELUMO DM RB HD HA TPSA 
1 1442.92 -47.61 -5.72 54.11 594.53 -553.82 -0.27308 -0.04987 7.80 6 10 15 256.29 
2 1801.56 -57.78 -7.18 67.53 756.67 -759.21 -0.26527 -0.04146 6.21 9 13 20 335.44 
3 1743.13 -51.53 -6.15 66.89 740.67 -710.11 -0.22100 0.00175 8.27 8 12 19 315.21 
4 1817.18 -43.72 -7.04 74.75 800.72 -655.39 -0.14423 -0.14108 14.77 12 10 18 301.05 
5 1112.70 -34.05 -3.44 40.77 446.37 -376.39 -0.22794 -0.04651 7.55 4 6 11 183.21 
6 755.02 -32.68 -4.01 28.54 302.24 -225.02 -0.25302 -0.04606 4.26 1 5 7 127.45 
7 737.08 -27.04 -2.99 27.90 286.24 -181.97 -0.25454 -0.04463 3.76 1 4 6 107.22 
8 1480.17 -53.11 -5.91 54.75 610.53 -594.10 -0.26526 -0.03515 5.46 6 10 16 265.52 
9 796.96 -35.31 -4.14 29.28 306.27 -251.56 -0.24548 0.01728 4.00 1 6 7 130.61 
10 779.09 -31.10 -3.12 28.65 290.27 -209.06 -0.25234 0.00795 3.20 1 5 6 110.38 
11 1393.96 -52.08 -6.97 56.52 578.53 -406.53 -0.23910 -0.00041 6.39 3 10 12 220.76 
12 1353.53 -50.33 -6.27 55.75 576.51 -396.04 -0.24712 0.00521 4.17 2 9 12 209.76 
13 1077.51 -31.80 -2.49 40.05 416.38 -298.59 -0.24421 -0.01044 6.91 4 5 9 145.91 
14 1096.72 -35.65 -3.52 40.69 432.38 -340.25 -0.23790 -0.00567 4.37 4 6 10 166.14 
15 1154.98 -32.24 -3.49 42.52 446.41 -332.21 -0.24770 -0.01768 3.30 5 5 10 155.14 
16 695.89 -19.27 -1.03 26.63 254.24 -91.86 -0.24242 -0.00687 5.33 1 2 4 66.76 
17 709.90 -24.68 -2.05 27.27 270.24 -141.38 -0.24776 -0.03413 3.26 1 3 5 86.99 
18 773.34 -19.97 -2.02 29.10 284.27 -127.56 -0.24124 -0.00586 1.77 2 2 5 75.99 
19 797.68 -19.11 -1.60 29.29 286.28 -147.23 -0.24342 -0.00751 2.77 2 2 5 75.99 
20 718.51 -17.37 -0.53 26.74 242.27 -84.41 -0.24625 0.01462 3.54 1 2 3 49.69 
21 1206.15 -37.98 -4.95 46.87 482.44 -328.56 -0.24934 -0.05253 3.76 4 6 10 166.14 
22 1178.42 -41.82 -5.44 43.80 478.41 -424.64 -0.26574 -0.04158 9.53 5 7 12 195.60 
23 746.42 -28.66 -2.59 28.10 288.26 -202.56 -0.25682 -0.03066 3.92 1 4 6 107.22 
24 1145.30 -39.96 -4.05 41.52 450.40 -404.53 -0.24626 -0.00343 5.94 4 7 11 186.37 
25 721.73 -23.85 -2.09 27.27 270.24 -142.79 -0.26369 -0.02437 5.16 1 3 5 86.99 
26 740.32 -29.49 -3.11 27.90 286.24 -185.85 -0.26617 -0.02590 4.86 1 4 6 107.22 
27 797.46 -23.32 -3.08 29.74 300.27 -176.55 -0.26297 -0.02516 5.05 2 3 6 96.22 
28 886.63 -26.81 -4.97 32.85 346.29 -252.05 -0.25055 -0.04583 3.80 3 4 8 125.68 
29 883.77 -29.04 -4.97 32.85 346.29 -249.37 -0.25355 -0.03643 3.74 3 4 8 125.68 
30 872.01 -23.24 -4.07 32.21 330.29 -208.74 -0.26586 -0.02684 4.44 3 3 7 105.45 
31 942.11 -23.86 -4.94 34.68 360.32 -238.54 -0.25358 -0.03559 3.63 4 3 8 114.68 
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4.3.2 Principal component analysis and hierarchical clustering 
Our simulation includes 31 flavonoids that are characterized by means of 13 
descriptors in addition to their biological activities pIC50.  
The crucial step in PCA is selecting the most significant components. In order to 
search for them, we use the cumulative percentage (Cum Percent) of total variation as 
most evident criterion which must exceed 80% [21]. The importance of the resulted 
PCs can be visualized through their percentages, where we can estimate that the two 
first principal components can explain 83.06 % of the total information as shown on 
Table 4.4. Thus, we can neglect the other components in data representation by PCA 
which helps us to compress the dataset.  
Table 4.4. Principal components. 










2 1.5960 11.400 83.056 
3 1.1758 8.399 91.454 
4 0.5822 4.158 95.613 
5 0.2962 2.116 97.728 
6 0.1374 0.981 98.710 
7 0.1083 0.774 99.483 
8 0.0509 0.363 99.847 
9 0.0119 0.085 99.932 
10 0.0081 0.058 99.990 
11 0.0007 0.005 99.995 
12 0.0006 0.004 99.999 
13 0.0001 0.001 100.000 
14 0.0000 0.000 100.000 
    
Chapter 4: Quantitative structure- antioxidant activity relationship study for flavonoids set 
 
 
- 61 - 
 
In order to understand the correlation between variables, we can perform the 
loading plot as illustrated by Figure 4.3. Whenever the absolute value of the loading 
plot is higher, its impact on the PCA- based model is greater [22]. 
 
Figure 4.3. Correlation circle. 
 
The correlation circle allows us to study the links between variables. We will 
therefore seek to find out whether there are groups of variables that are strongly 
correlated with each other. If such groups exist, then all the variables in a given group 
will be "synthesizable" by a synthetic variable.  
From the above correlation circle, we observe that: 
-HD, HA, TPSA, V, Pol, and MW form a subgroup highly correlated because their 
corresponding vectors are closely superposed. 
-The energies HE and HF are negatively correlated with the topologic parameters in 
the first factorial axis. 
-The second factorial axis is predominantly dependent on EHOMO and ELUMO. 
Besides, we carry out a hierarchical clustering which is a multivariate technique 
that leads to assembly similar observations. The clusters share close values according 
to their descriptors [23].  
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Figure 4.4 shows that the data set is divided into four different clusters. Obviously, 
we can distinguish between them as following:  
 Group I assembles the molecules: 1, 2, 3, 8, 11, and 12. They are similar in 
enclosing a glycoside group with a molar weight more than 575 uma.   
 Group II contains just the 4th molecule; it is the unique derivative that contains a 
synapoyl group. 
 Group III gathers the derivatives: 5, 13, 14, 15, 21, 22, and 24. This category can 
be distinguished from the first one by containing a glycoside group, yet with a molar 
weight less than 500 uma. 
 Group IV collects the rest of the set. They are simple flavonoids with a molar 
weight less than 500 uma. 
 
 
Figure 4.4. Hierarchical clustering. 
Figure 4.5 illustrates the distribution of the molecules within the two PC. 
 
Figure 4.5. Score plot. 




4.3.3 QSAR modeling using Gaussian Process
The data set is divided into training and test sets. The test set 
selected from the three dominant clusters I, III, and IV with a ratio of about 1:5. The 
excluded molecules used to validate the model are: 
We can confirm that the EHOMO is the most influencing factor in the antioxidant 
activity with a total sensitivity of 27.03 %. That is to say that about 27 % of the 
variation in the activity can be explained by this parameter. Moreover, factors with 
high θ values have a significant impact on the prediction formula as EHOMO in this 
case with θ value of 27.86
Habitually, the Gaussian processes 
with no-error-term models, where ther
values [24]. This similarity
(R2) and the average relative error 
To verify the predictive capacity of the model (Figure 
was established using the predictive 
Figure 4.6. Comparative bar chart between observed (obs) and predicted (pred) 
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7, 12, 15, 19, and 2
 [24].  
interpolate perfectly the data. They 
e is a similarity between input and 
 can be shown by calculating the correlation coefficient 
(ARE) for the training set. 
4.6), an external validation 
R2 (R2pred) and AREpred on the test set.
pIC50 of the test set. 
given as following: 
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 Training set: 
R2=0.99, and ARE=0.99. 
 Test set: 
R2pred=0.86, and ARE pred = 0.93. 
We can confirm that the model has a good predictive capacity with R2pred of 0.86, 
which exceeds the inferior limit of 0.6 [25] and ARE pred equals to 0.93. 
4.4 Structure-activity relationship of the studied flavonoids  
As seen in chapter 1, donating hydrogen is basic in explaining antioxidant capacity 
of flavonoids. They are stabilized after scavenging free radicals by resonance. 
Depending on the QSAR study, we can confirm that EHOMO has a high impact on 
the antioxidant activity since it is directly related to the reactivity of the derivatives. It 
is also found that the number of OH may have a positive effect on the activity till a 
limit of 10. After that, we observe an inverse relationship between them. That may be 
due to the presence of glycosides where we observe, on the Figure 4.7, the presence of 
the flavonoids that belong to the cluster I (molecules 1, 2, and 3) with a high MW in 
this part of the graph. Thus, that confirms that the number of OH groups, particularly 
that belong to glycosides is not enough to increase the antioxidant activity.   
 
Figure 4.7. Effect of HD on the antioxidant capacity. 
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4.5 Conclusion 
QSAR studies are often established using the common techniques as multiple 
linear regressions. The objective of this chapter was to carry out a QSAR model using 
Gaussian process regression which is seldom used in this approach. From our results, 
we proved that this method is able to predict the antioxidant activity of some 
flavonoids with a good level. This capacity can be improved by enlarging the training 
data set. 
Depending basically on the molar weight and the presence of glycosides, our set 













Chapter 4: Quantitative structure- antioxidant activity relationship study for flavonoids set 
 
 
- 66 - 
 
References 
[1] M. Zaynab, M. Fatima, S. Abbas, Y. Sharif, M. Umair, M.H. Zafar, K. Bahadar, 
Microb. Pathog. 124 (2018) 198. 
[2] A. Dragan,  D.A. Dušanka, B. Drago, R. Vesna, L. Bono, T. Nenad, Curr. Med. 
Chem. 14 (2007) 827-845.  
[3] S.D.S. Banjarnahor, N. Artanti, Med. J. Indones. 23 (2014) 240.   
[4] K.J. Murphy, K.M. Walker, K.A. Dyer, J. Bryan, Nutr Res. 61 (2019) 70.  
[5] P.Truchado, F. Ferreres, F.A. Tomas-Barberan, J. Chromatogr. A. 1216 (2009) 
7241. 
[6] D. Kruzlicova, M. Danihelova, M. Veverka, Nova Biotechnol. et Chim. 11 (2012) 
37. 
[7] D. Tasdemir, M. Kaiser, R. Brun, V. Yardley, T.J. Schmidt, F. Tosun, P. Rüedi, 
Antimicrob. Agents Chemother. 50 (2006) 1352-1364. 
[8] X.M. Chen, A.R. Tait, D.D. Kitts, Food chem. 218 (2017) 15. 
[9] D. Veeramuthu, W.R. Tharsius Raja, N.A. Al-Dhabi, I. Savarimuthu, Flavonoids: 
Anticancer Properties. Biosynthesis to Human Health, IntechOpen, 2017. 
[10] B.J. Lumbiny, Z. Hui, M.A. Islam, J. Asiat. Soc. Bangladesh Sci. 39 (2013) 191. 
[11] S. Das, I. Mitra, S. Batuta, M. Niharul, A. Kunal Roy, N. Ara Begum, Bioorg. 
Med. Chem. Lett. 24 (2014) 5050. 
[12] W.A. Peer, A.S. Murphy, Flavonoids as signal molecules: Targets of Flavonoid 
Action. Science of flavonoids, Erich Grotewold, USA, 2006. 
[13] M. Okawa, J. Kinjo, T. Nohara, M. Ono, Biol. Pharm. Bull. 24 (2001) 1202- 
1205. 
[14] J. Hu, W. Ma, N. Li, K.J. Wang, J. Mex. Chem. Soc. 61 (2017) 282-289. 
Chapter 4: Quantitative structure- antioxidant activity relationship study for flavonoids set 
 
 
- 67 - 
 
[15] Hyper Chem (Molecular Modeling System) Hypercube, Inc., 1115 NW, 4th 
Street, Gainesville, FL 32601, USA (2008). 
[16] M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. 
Cheeseman, H. Nakatsuji, Gaussian 09, Revision E. 01, 2009, Gaussian. Inc., 
Wallingford CT. 
[17] MarvinSketch, Chemaxon. (2020). (http://www.chemaxon.com) 
[18] Database. http://www.molinspiration.com. 
[19] JMP 8.0.2, SAS Institute Inc., 2009. 
[20] M. Rossi, L.F. Rickles, W.A. Halpin, Bioorg. Chem. 14 (1986) 55-69. 
[21] I.T. Jolliffe, Principal Component Analysis, 2nd Edition, Library of Gongress 
Cataloging-in- Publication Data, Springer –Verglas, New York, 2002. 
[22] C. Yoo, M. Shahlaei, Chem. Biol. Drug Des. 91 (2018) 137-152. 
[23] SAS Institute Inc. 2017. JMP® 13 Multivariate Methods, Second Edition. Cary, 
NC: SAS Institute Inc.  
[24] SAS Institute Inc. 2018. JMP® 14 Predictive and Specialized Modeling. Cary, 
NC: SAS Institute Inc. 




















The antioxidants become recently the subject of many researches since they 
contribute in the well being of humans. They combat the ageing related diseases and 
scavenge the free radicals originated from the new harmful conditions of life as 
pollution, smoking, and stress. The antioxidants are also largely used in the 
formulation of drugs and food. They are even added to the anticancer drugs to boost 
their activity. In addition, they are vital for preserving medicines and food against 
oxidation.  
This work aimed to establish a QSAR study for two antioxidant sets, benzofurans 
and flavonoids. Depending on the IC50 values, both of the sets include molecules 
with high antioxidant capacity, what makes them sources for new derivatives that may 
be used in drug and food industries.    
Neural nets and Gaussian process were used to perform the modeling. These two 
techniques show a good predictive capacity even with small training sets. The Rpred
2 
values exceed the inferior limit of 0.6.  
The Gaussian process is widely used in physics and computer simulation; 
nevertheless, it is rarely explored in QSAR approaches. This work and few others [1] 
confirm that it may be a powerful tool in these studies.  
We could also confirm that EHOMO has an important impact on the antioxidant 
capacity since it is taken in the QSAR models as one of the most efficient factors for 
both benzofurans and flavonoids. It is related to the reactivity of derivatives which is 
demanded in the antioxidant activity through donating hydrogen atoms to the free 
General conclusion 
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radicals [2]. Hydroxylation is seen to have a limited effect; it is not sufficient to 
increase the antioxidant capacity. It is possibly related to the position of OH groups, 
the conjugaison and the MW of the compounds. 
Drug-likeness studies were also performed to select the drug-like molecules 
according to Lipinski and Veber rules, besides the calculation of the lipophilicity 
indices.  
Multivariate techniques are very helpful to simplify the interpretation of data, 
particularly for large sets. They offer in laps of time wide information about their 
distribution. In our case, the flavonoids were perfectly clustered into four groups. That 
may help to establish QSAR studies on distinguished clusters as in the use of 
Gaussian process since this last is based on similarity between samples. 
To improve the quality of QSAR models, we can suggest as perspectives for this 
work: 
 Enlarge the data sets. 
 Change the ANN and GP parameters. 
 Apply separately the models on clusters and compare the results with the whole 
sets. 
 Introduce others descriptors such as charges to improve the quality of correlations 
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a b s t r a c t
In order to explore the relationship between the antioxidant activity and structure of fifteen benzofuran
derivatives, we carried out a QSAR study using multiple linear regression (MLR) and artificial neural
network (ANN) methods. Six descriptors were used as input data (molar weight, surface area, octanol-
water partition coefficient, hydration energy, highest occupied molecular orbital energy and lowest
unoccupied molecular orbital energy). The electronic properties were derived at the B3LYP/6e31 G (d,p)
level. Benchmarks on furan and benzofuran subunits and their comparison to the experiment showed
that this level of theory is good enough. The output data correspond to the antioxidant activity as given
by IC50. The predicted properties are in agreement with experimental values. Our study shows that 80%
of studied molecules are in accordance with the Lipinski and Veber rules and reach the optimal lip-
ophilicity indices. In addition, statistical analysis reveals that ANN technique with (6-2-1) architecture is
more significant than MLR model.
© 2019 Elsevier B.V. All rights reserved.
1. Introduction
Damage to cells caused by free radicals is believed to play a
central role in disease progression [1] including cancer [2], car-
diovascular [3] and Alzheimer diseases [4]. The need for antioxi-
dants becomes even more critical with increased exposure to free
radicals caused by pollution, cigarette smoke, drugs, illness and
stress [1]. Scientists commonly agree that a combination of anti-
oxidants, rather than unique entities, may be more efficient in the
end. Antioxidants can be very helpful in improving the quality of
life, for instance, by preventing or delaying the onset of degener-
ative diseases [5]. They are able to stabilize or disable free radicals
before they attack the cells. In addition, they are essential for
maintaining optimal cellular and system health and well-being [1].
In this context, oxygen heterocycles exhibit diverse biological and
pharmacological activities due in part to the similarities with many
natural and synthetic molecules with known biological activity.
Among these compounds, furan [6] and benzofuran derivatives
show efficient antioxidant activity. These derivatives exhibit also
high potentialities for use as pharmacological agents. Indeed, these
ring systems have emerged as powerful scaffolds for many bio-
logical evaluations and play an important role in the design and
discovery of new physiological/pharmacologically activemolecules.
They can arrange to yield potent and selective drugs.We refer to the
recent review by Khanam and Shamsuzzaman [7] for a wide pre-
sentation of the progress in the numerous pharmacological activ-
ities of benzofuran derivatives and of their applications in
medicine.
The present theoretical contribution concerns the study of the
relationship between antioxidant activity and the structure of
fifteen benzofuran derivatives as recently determined by Hsieh
et al. [6]. The structures of these compounds are specified in Table 1
as constructed using the Molinspiration Database [8]. Their corre-
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(DPPH) is compiled from the literature (Table 1). All these mole-
cules show a free radical scavenging activity with IC50 values
ranged between 7.8± 1.6 and 33.8± 2.8 mM [6].
Many different chemometric methods, such as multiple linear
regression (MLR) [9e11], partial least squares regression (PLS) [12],
different types of artificial neural networks (ANN) [13e16], genetic
algorithms (GA) [17], and support vector machine (SVM) can be
employed to deduce correlation models between the molecular
structure and properties [9]. At present, we derive a quantitative
structureeactivity relationship (QSAR) model using multiple linear
regression (MLR) as well as artificial neural network (ANN)
methods for the series of benzofuran derivatives of Table 1. After-
wards, Lipinski and Veber rules, and lipophilicity indices are
applied to identify “drug-like” compounds. For electronic structure
computations, we used Becke's three-parameter Lee-Yang-Parr
(B3LYP) [18] density functional theory (DFT) in conjunction with
the 6-31G (d,p) basis set. This level of theory is viewed to be ac-
curate enough after benchmarks on the structure and the vibra-
tional spectroscopy of furan and benzofuran subunits using post
Hartree-Fock (MP2, Coupled Clusters) methods and their compar-
ison to experimental (IR, mw) data.
2. Benchmarks on furan and benzofuran
2.1. Equilibrium geometries of furan and of benzofuran
The most efficient theoretical approach to be used for the larger
benzofuran derivatives of interest in the present study may be
selected by comparison with experimental results. We started
hence our investigations by optimizing the furan and benzofuran
equilibrium structures in order to select the most reliable predic-
tive method comparatively to experiment and with reduced
computational cost. Indeed, a compromise between accuracy and
computational cost (both CPU and disk occupancy) should be found
in order to be able to compute the properties of our series of the
benzofuran derivatives.
Table 2 gives the equilibrium structures of furan and of benzo-
furan as computed at the B3LYP/6-31G (d,p), B3LYP/cc-pVDZ, MP2/
6-31G (d,p), MP2/cc-pVDZ, MP2/aug-cc-pVTZ and CCSD/6-31G
(d,p) and CCSD/cc-pVDZ levels of theory. These computations are
carried out using the GAUSSIAN 09 program package [21]. Table 2
lists also the corresponding experimental geometrical parameters
as measured using microwave spectroscopy [19,20]. Since furan
and benzofuran are planar, the calculated dihedral angle values are
either 0 or 180.
Close inspection of Table 2 shows that CCSD method in
conjunction with either the 6-31G (d,p) or the cc-pVDZ basis sets
performs quite well since the differences between the computed
and the measured equilibrium distances amount only to few
thousandths of Å. The in-plane angles are also close to the exper-
imental ones (within less than 1). As established in the literature,
CCSD approach can be used as a referencemethod to compare with.
Interestingly, the less computationally demanding approaches i.e.
B3LYP/6-31G (d,p), B3LYP/cc-pVDZ, MP2/6-31G (d,p), MP2/cc-
pVDZ, MP2/aug-cc-pVTZ, perform also quite well compared to
CCSD and to experiments since they lead to equilibrium structural
parameters which differ by less than few hundredths of Å for the
distances and less than 1 for the angles. Especially, a good
Table 1
Chemical structures and experimental activity of the molecules under study [6]. N is the number of the compound as used presently.
N Structure IC50 N Structure IC50 N Structure IC50
1 18.5 2 20.6 3 33.8
4 18.0 5 14.6 6 18.4
7 19.4 8 7.8 9 12.8
10 10.8 11 28.6 12 16.8
13 25.4 14 11.7 15 26.2
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agreement can be observed between the predicted B3LYP/6-31G
(d,p) and experimental data. From that, we can conclude that the
DFT/B3LYP method is appropriate enough for studies of benzofuran
derivatives.
2.2. Vibrational analysis
Accurate calculations of anharmonic frequencies of molecular
systems allow correct identification of molecules through the
assignment of their experimental RAMAN, IR or Far-IR spectra. Such
computations are also needed to establish the reliability of the
derivatives of the potentials, i.e. force fields, in semi empirical ap-
proaches. Obviously, this is crucial for accurate predictions of
thermal contributions to enthalpies and entropies and of the
reactive properties of these compounds using such methods. Here,
we used second order perturbation theory (VPT2) approach as
implemented in GAUSSIAN and MOLPRO [22] to evaluate the
anharmonic vibrational frequencies of isolated furan and benzo-
furan. These data were calculated by means of B3LYP/6e31 G (d,p).
The results are listed in Table 3, where they are compared to the
respective FT-IR experimental data.
The benzofuran is a planar asymmetric rotor with Cs symmetry.
The vibrations separate into 27 a' (in-plane) and 12 a00 (out-of-
plane) fundamentals [23]. Furan is also a planar, near oblate sym-
metric top rotor. It possesses 8 a1, 3 a2, 7 b1, and 3 b2 vibrations [24]
(specified in Table 3). In brief, the comparison of the B3LYP/6-31G
(d,p) computed and measured fundamentals for furan and benzo-
furan shows differences of less than 10 cm1 between both sets of
data. Again, this confirms the good performance of B3LYP/6-31G
(d,p) chosen theoretical level for the derivation of properties of
larger benzofuran derivatives.
2.3. 3D molecular electrostatic potential surface maps (3D MESP) of
furan and of benzofuran
Fig. 2 shows the 3D molecular electrostatic potential surface
maps (3D MESP) of furan and of benzofuran. MESP allows under-
standing various physical and chemical phenomena such as mo-
lecular reactivity behavior, intermolecular interactions, molecular
recognition, electrophilic reactions, substituent effects and the in-
teractions induced by the reagents, for example between a drug
and its cellular receptor [11].
As can be seen in Fig. 2, furan and benzofuran present negative
electrostatic potentials (red zone) around the oxygen atom due to
its high electronegativity. An orange region can be observed around
the carbon atoms of the five-ring of furan and the benzene ring of
benzofuran. Thus, these parts may be subject to electrophilic at-
tacks. We can see also positive electrostatic potentials (blue zone)
around the atoms of hydrogens, which explain that these atomic
sites are susceptible for nucleophilic attacks. In sum, furan and
benzofuran exhibit common characteristics, which may be helpful
for a qualitative understanding of the electrostatic interactions that
may take place between reagents or enzyme active sites and the
benzofuran derivatives under study.
3. Quantitative structure activity relationships (QSAR) study
When chemical or physical properties and molecular structures
are derived from numbers, it is often possible to propose mathe-
matical relations connecting them, which allow making quantita-
tive predictions. The obtained mathematical expressions can then
be used as a predictive means of the biological response for similar
structures. They are widely used in the pharmaceutical industry to
Table 2
Bond lengths (in Å) and valence angles (in degree, ) of furan and of benzofuran. See Fig. 1 for the numbering of the atoms. Experimental data for furan and for benzofuran (See
NOTE 1) are from Ref. [19] and Ref. [20], respectively.
Furan
Parameters Exp. B3LYP MP2 CCSD
6-31G (d,p) cc-pVDZ 6-31G (d,p) cc-pVDZ aug-cc-pVTZ 6-31G (d,p) cc-pVDZ
O1eC2 1.3621 1.364 1.363 1.366 1.363 1.360 1.367 1.365
C2eC3 1.3609 1.360 1.364 1.366 1.378 1.365 1.358 1.369
C3eC4 1.4309 1.436 1.438 1.427 1.436 1.426 1.440 1.450
C2eH6 1.0750 1.079 1.086 1.075 1.088 1.075 1.075 1.089
C3eH7 1.0768 1.080 1.087 1.076 1.089 1.076 1.076 1.090
O1eC2eC3 110.68 110.5 110.6 110.5 110.8 110.4 110.8 111.1
C2eC3eC4 106.50 106.1 106.0 106.2 105.8 106.1 106.0 105.6
C2eO1eC5 106.55 106.8 106.8 106.6 106.8 106.9 106.3 106.5
O1eC2eH6 115.92 115.8 115.7 115.7 115.8 115.8 115.7 115.8
C2eC 3-H7 127.95 126.5 126.5 126.2 126.3 126.1 126.5 126.6
Benzofuran
O1eC2 e 1.370 1.370 1.372 1.369 1.365 1.372 1.370
C2eC3 1.409 1.408 1.410 1.407 1.417 1.405 1.400 1.409
C3eC4 1.470 1.444 1.446 1.438 1.446 1.435 1.450 1.458
C4eC5 1.350 1.355 1.359 1.361 1.372 1.360 1.353 1.364
O1eC5 1.362 1.374 1.374 1.375 1.373 1.369 1.377 1.376
C2eC9 1.452 1.390 1.392 1.393 1.401 1.389 1.393 1.402
C3eC6 1.407 1.403 1.406 1.405 1.413 1.402 1.404 1.413
C6eC7 1.397 1.392 1.349 1.390 1.340 1.388 1.390 1.399
C7eC8 1.409 1.408 1.410 1.410 1.419 1.407 1.410 1.419
C8eC9 1.396 1.393 1.396 1.392 1.401 1.390 1.391 1.400
C2eO1eC5 106.7 106.0 105.9 106.0 105.6 105.9 105.8 105.5
O1eC2eC3 110.4 110.3 110.4 110.5 110.8 110.5 110.7 110.9
C2eC3eC4 105.2 105.3 105.3 105.9 105.2 105.4 105.3 105.1
C3eC4eC5 105.4 106.0 106.0 105.6 105.8 105.9 105.6 105.8
O1eC5eC4 112.3 112.4 112.4 112.4 112.6 112.3 112.5 112.8
C2eC3eC6 119.8 118.7 118.9 118.8 119.0 118.8 119.0 119.2
C3eC6eC7 117.6 118.4 118.4 118.3 118.3 118.2 118.3 118.3
C6eC7eC8 121.3 121.4 121.4 121.5 121.4 121.5 121.3 121.2
C7eC8eC9 121.4 121.3 121.2 121.4 121.3 121.4 121.4 121.3
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identify promising compounds, especially at early stages of drug
discovery [27].
Relationships between the physicochemical properties of
chemical substances and their biological activities can be derived
using QSAR (Quantitative Structure-Activity Relationships)
concept. These models can also be used to predict the activities of
new chemical entities and for their design [28]. Therefore, the
biological activity is quantitatively expressed as the concentration
of substance necessary to obtain a certain biological response. For
that purpose, multiple linear regression, MLR, and artificial neural
networks (ANNs) are used. The accuracy of such models is mainly
evaluated by the correlation coefficient R2 [9] and the average
relative error ARE [29] (see NOTE 2). The MLR and ANN models
were generated using the software JMP 8.0.2 [30].
Table 3
Anharmonic vibrational frequencies (in cm1) of furan and of benzofuran as computed using B3LYP/6e31 G (d,p). We give also the experimental data.
furan Benzofuran
Mode N Sym. B3LYP/6e31 (d,p) Exp. [25]. Mode N Sym. B3LYP/6e31 (d,p) Exp [26].
1 a1 3165 3169 1 a0 3164.6 3158.0
2 a1 3143 3140 2 a0 3126.4 3124.5
3 a1 1494 1491 3 a0 3085.2 3094.0
4 a1 1392 1385 4 a0 3056.9 3077.0
5 a1 1150 1140 5 a0 3064.6 3067.0
6 a1 1075 1067 6 a0 3028.6 3047.0
7 a1 1005 995 7 a0 1631.2 1617.0
8 a1 874 870 8 a0 1601.4 1595.0
9 a2 865 864 9 a0 1558.1 1542.8
10 a2 713 722 10 a0 1487.1 1478.5
11 a2 606 600 11 a0 1461.0 1456.8
12 b1 3156 3161 12 a0 1373.0 1346.2
13 b1 3133 3130 13 a0 1343.5 1329.0
14 b1 1577 1558 14 a0 1274.2 1264.2
15 b1 1270 1267 15 a0 1259.6 1252.9
16 b1 1181 1181 16 a0 1181.6 1179.9
17 b1 1048 1043 17 a0 1164.0 1161.0
18 b1 878 873 18 a0 1138.4 1130.8
19 b2 827 838 19 a0 1112.4 1107.0
20 b2 747 745 20 a0 1044.0 1035.8
21 b2 612 603 21 a0 1018.6 1007.0
22 a0 901.7 900.1
23 a0 855.4 855.2
24 a0 770.5 767.6
25 a0 613.6 611.6
26 a0 543.7 538.7
27 a0 404.3 400.3
28 a00 965.9 970.0
29 a00 927.6 929.0
30 a00 861.4 861.1
31 a00 848.0 848.0
32 a00 770.4 763.0
33 a00 751.6 745.6
34 a00 737.2 731.5
35 a00 589.6 584.0
36 a00 575.6 569.0
37 a00 425.2 417.9
38 a00 251.3 246.3
39 a00 217.6 211.2
Fig. 1. Structures of furan (left) and of benzofuran (right). We give also the atom numbering.
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The equilibrium geometries and the highest occupied molecular
orbital energy (EHOMO) and lowest unoccupied molecular orbital
energy (ELUMO) of benzofuran derivatives were determined at the
B3LYP/6-31G (d,p) level of theory. We list in Table S1 of the sup-
plementary material the Cartesian coordinates of the optimized
benzofuran derivatives equilibrium structures. Then, the QSAR
properties module from Hyper Chem 8.08 [33] was used to calcu-
late: molar weight (MW), surface area (S), volume (V), refractivity
(R), polarizability (P), octanol-water partition coefficient (log P) and
hydration energy (HE). Finally, MarvinSketch17.1.2 Software [34]
was employed to compute: hydrogen bond donors (HBD), hydrogen
bond acceptors (HBA), number of rotatable bonds (NRB) and polar
surface area (PSA).
3.1. Multiple linear regression (MLR)
MLR is one of the earliest and still one of the most commonly
used methods for constructing QSAR mathematical models [31]
because of its simplicity, transparency, reproducibility, and easy
interpretability [32]. At present, QSAR was carried out on a series of
fifteen furan derivatives (Table 1). In this work, nine descriptors
were chosen to describe the structure of the benzofuran de-
rivatives. Table 4 shows the values of the calculated descriptors
used in order to establish the quantitative structure - antioxidant
activity. The data set was randomly divided into two sets: a training
set (twelve compounds) and a testing set (three compounds: 6, 12
and 15) at a ratio of 80:20. Correlation matrix between parameters
was performed on all nine descriptors. Nevertheless, the analysis
revealed six independent descriptors for the development of the
model.
The resulting MLR QSAR model is represented by the following
equation:
IC50 ¼ 212:620  0:785 MW þ 0:397 S  44:368 log P
þ 9:274 HE  1815:594 EHOMO  2746:546 ELUMO
(1)
where, IC50 is the response or dependent variable. MW, S, log P, HE,
EHOMO and ELUMO are descriptors (features or independent vari-
ables). Within the regression, the coefficients in front of these de-
scriptors are optimized [32].
For validation of the model, we plot in Fig. 3 the experimental
activities against the predicted values as determined by equation
(1). We can observe that the predicted IC50 values are in an
acceptable agreement and regular distribution with experimental
ones with R2¼ 0.64 and ARE of 0.74.
The positive values of S and HE coefficients indicate their pro-
moter effect on the response, whereas the other factors (MW, log P,
EHOMO and ELUMO) exhibit an opposite effect on IC50. QSAR models
aim also to define the importance of factor's effects. In our case, the
Fig. 2. 3D MESP for furan (left) and for benzofuran (right). The results are shown by color, from red (most negative) to blue (most positive).
Table 4
Values of molecular descriptors used in the QSAR study. We give the molar weight (MW, amu), surface area (S, Å2), volume (V, Å3), refractivity (R, Å3), polarizability (P, Å3),
octanol-water partition coefficient (log P), hydration energy (HE, kcal/mol), energies of the HOMO (EHOMO, eV) and LUMO (ELUMO, eV) and IC50 (in mM) (as given in Table 1).
Compound MW S V R P log P HE EHOMO ELUMO IC50
1 242.23 419.57 685.41 74.61 25.35 2.44 23.21 0.238 0.025 18.5
2 321.13 440.83 732.74 82.15 27.97 2.39 22.50 0.240 0.008 20.6
3 305.13 433.63 711.92 80.54 27.33 1.36 16.04 0.236 0.012 33.8
4 321.13 439.52 729.18 82.15 27.97 2.39 20.06 0.235 0.013 18.0
5 337.13 458.90 765.50 83.75 28.61 3.41 27.98 0.254 0.015 14.6
6* 321.13 447.86 741.16 82.15 27.97 2.39 22.68 0.250 0.018 18.4
7 416.02 474.28 802.32 91.29 31.23 3.36 25.56 0.257 0.004 19.4
8 400.02 471.11 790.38 89.68 30.60 2.33 22.03 0.258 0.005 7.80
9 258.23 426.19 703.13 76.22 25.98 3.46 28.55 0.237 0.023 12.8
10 242.23 418.17 682.36 74.61 25.35 2.44 22.56 0.234 0.026 10.8
11 321.13 450.12 745.24 82.15 27.97 2.39 22.53 0.251 0.017 28.6
12* 340.33 569.21 958.60 100.37 35.05 2.27 22.81 0.237 0.017 16.8
13 340.33 582.08 965.45 100.37 35.05 2.27 22.70 0.239 0.017 25.4
14 356.33 590.10 984.78 101.98 35.69 3.29 28.71 0.240 0.018 11.7
15* 340.33 542.93 941.88 100.37 35.05 2.27 22.09 0.241 0.016 26.2
* corresponds to test molecules.
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surface is presented as the most influencing parameter on IC50,
followed by the molar weight and the hydration energy. The least
important factor is log P. As the antioxidant activity is required to be
improved, i.e. IC50 decreased, it will be recommended to increase
MW and reduce S and HE.
3.2. Artificial neural networks
Artificial neural networks (ANNs) models are non-linear models
useful to predict the biological activity of large data sets of mole-
cules [15]. In contrast to classical statistical methods such as
regression analysis or partial least squares analysis, ANNs enable
the investigation of complex and nonlinear relationships. Neural
networks are therefore ideally suited for use in drug design and
QSAR [35]. They are applied for simulating various non-linear
complex systems of pharmaceutical, engineering, psychology and
medicinal chemistry domains [36]. For instance, ANN was suc-
cessfully used for the prediction and synthesis of new organic
chemical compounds [16].
In this work, ANN contained six inputs corresponding to the six
descriptors selected from the correlation matrix, two hidden neu-
rons, and one output neuron which is IC50 (Fig. 4). The number of
artificial neurons in the hidden layer was adjusted experimentally
[37], two neurons in the hidden layer permitted to attain the best
correlation between experimental and predicted data. Then, the
ANN was trained using Gauss Newton method. A good correlation
of experimental and predicted IC50 by ANN is found. This is shown
in Fig. 5, and illustrated by R2 and ARE values of R2¼ 0.99 and
ARE¼ 0.99.
From both results of training and test sets (Fig. 5), we can
conclude that the ANN model with (6-2-1) architecture is able to
establish a satisfactory relationship between the six descriptors and
the antioxidant activity. For instance, all test molecules (6, 12 and
15) are in a good agreement with the two models.
Table 5
Drug-likeness parameters and lipophilicity indices of benzofuran derivatives. See text and NOTES 3e7 [40e43] for the definition of the parameters given here.
Compound Lipinski rules Veber rules Lipophilicity indices
MW (amu) logP HBD HBA PSA (Å2) NRB LipE LELP
<500 <5 <5 <10 <140 <10 >5 10< LELP< 10
1 242.23 2.44 3 3 73.82 1 7.17 6.63
2 321.13 2.39 3 3 73.82 1 7.08 6.92
3 305.13 1.36 2 2 53.6 1 5.83 3.91
4 321.13 2.39 3 3 73.82 1 7.13 6.84
5 337.13 3.41 4 4 94.05 1 8.24 10.07
6 321.13 2.39 3 3 73.82 1 7.12 6.85
7 416.02 3.36 4 4 94.05 1 8.07 10.70
8 400.02 2.33 3 3 73.82 1 7.44 6.52
9 258.23 3.46 4 4 94.05 1 8.35 9.60
10 242.23 2.44 3 3 73.82 1 7.41 6.32
11 321.13 2.39 3 3 73.82 1 6.93 7.14
12 340.33 2.27 3 4 100.13 5 7.04 8.49
13 340.33 2.27 3 4 100.13 5 6.86 8.82
14 356.33 3.29 4 5 120.36 5 8.22 12.39
15 340.33 2.27 3 4 100.13 5 6.85 8.85
Fig. 3. Correlation of experimental and predicted IC50 (in mM) as derived using MLR.
Fig. 4. Structure of ANN.
Fig. 5. Correlation of experimental and predicted IC50 as calculated by ANN.
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3.3. Drug-likeness screening
Drug-likeness is a qualitative concept used in drug design [38]. It
is described to encode the balance among the molecular properties
of a compound that influences its pharmacodynamics, pharmaco-
kinetics and ADME (Absorption, Distribution, Metabolism and
Excretion) in human body [39]. Several rules have been proposed to
evaluate drug-likeness. Themost commonly used are Lipinski's rule
of five [40] (see NOTE 3), Veber rules [41] (see NOTE 4), and lip-
ophilicity indices [42,43], which are viewed to be quite effective
and efficient [44]. These represent guidelines and not absolute
values to attest that a compound is a drug-like or not. Indeed,
pharmacokinetic parameters are strongly influenced in vivo by the
physicochemical properties of a drug [45]. Moreover, successful
drug discovery not only requires the optimization of physico-
chemical parameters, but also more complex parameters related to
toxicity and bioavailability defined as lipophilic efficiency indices
[46]: ligand lipophilic efficiency LipE (see NOTE 5), ligand efficiency
(LE see NOTE 6) and ligand-efficiency dependent lipophilicity LELP
(see NOTE 7) [42]. At present, we evaluated the oral bioavailability
of the fifteen benzofuran derivatives under study. Our parameters
can be used to increase the overall efficiency of drugs at different
stages of discovery [45].
Table 5 presents the drug-likeness parameters and lipophilicity
indices of the benzofuran derivatives under investigation. We give
also the criteria to satisfy the lipophilicity indices and the Lipinski
and Veber rules. As can be seen there, all compounds satisfy the
rules, except compounds 5, 7 and 14 which show a slight out of
range LELP (<-10) [47]. This table shows also that these compounds
havemolecular weights of less than 500 Da. Moreover, Table 4 gives
the values of log P, which is a parameter used to estimate molecular
hydrophobicity. For all studied compounds, log P is less than zero,
so these molecules possess high water solubility and, in principle,
poor membrane permeation capacity, which may be partly reme-
died by the small molecular weight. Hydrogen bonds increase
solubility in water and must be broken for the compound to
permeate into and through the lipid bilayer membrane. Thus, an
increasing number of hydrogen bonds reduces partitioning from
the aqueous phase into the lipid bilayer membrane for permeation
by passive diffusion [44]. We see that all the screened molecules
have a number of hydrogen bonds in the appropriate interval of
Lipinski. In addition, all benzofuran derivatives show PSA values in
the range of 53e120 Å2, which permit them to correlate very well
with the human intestinal absorption, Caco-2 monolayer's
permeability, and blood-brain barrier penetration [48]. We can
note also that compounds 12, 13, 14 and 15 are likely to be the most
flexible with a number of rotatable bonds of 5.
In the studied set, LipE takes values between 5.83 and 8.35.
Thus, this set would have a high quality as lead compounds, pro-
vided that LELP is situated in the suggested range10< LELP<10 to
guarantee that molecules reach both size and lipophilicity criteria,
which is the case for all the studied compounds except three
molecules (5, 7 and 14) having LELP inferior than the minimum
limit (10.07, 10.70, 12.39).
In general, according to the results listed in Table 5, we can es-
timate that all benzofuran derivatives satisfy the Lipinski and Veber
rules, so they would not have problems with oral bioavailability.
80% of compounds reach an LELP in the suggested range10< LELP
<10.
4. Summary and conclusion
A quantitative analysis of the structure-antioxidant activity
relationship of fifteen antioxidant benzofuran derivatives is per-
formed. QSAR models were obtained using multiple linear regres-
sion (MLR) and artificial neural network (ANN) techniques. Our
work shows that this series of compounds obey the Lipinski's rule
of five. These molecules satisfy also Veber's rules with NRB <10 and
PSA <140. According to the calculated LELP values, these de-
rivatives, expect compounds 5, 7 and 14, could have promising
results in the clinic tests.
From a mythological point of view, we used first principles ap-
proaches to treat the furan and benzofuran subunits. The compar-
ison of the spectroscopic parameters of these entities with
experiment showed that the B3LYP/6e31 G (d,p) approach is suf-
ficiently reliable. In addition, its low computational cost allows for
investigating larger molecular systems. Afterwards, we showed
that both ANN and MLR methods provide similar QSAR model ac-
curacy. For instance, Fig. 6 reveals that MLR and ANN predict almost
coinciding IC50s, whereas some systematic deviations can be
observed with the measured IC50s. In sum, to improve the QSAR
models, research needs to be conducted with more activity data of
similar compounds and molecular parameters [49].
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5. Notes
NOTE 1: The experimental values of bond length and angles are
estimated from data concerning the 5-membered rings taken
frommicrowave studies of thiophene and furan, and data for the
6-membered ring taken from a crystal study of 3-indolylacetic
acid [20].
NOTE 2: The MLR and ANN models were generated using the
software JMP 8.0.2 [30]. The accuracy of models is mainly
evaluated by the correlation coefficient R2 and the average
relative error ARE. The relations of R2 [9] and ARE [29] are given










N ; where: ym is the desired output, bym is
the predicted value by model, y is the mean of dependent var-
iable, and N is the number of the molecules in the data set.
NOTE 3: According to Lipinski's rule [40], a good absorption is
achieved if: (i) molecular weight is under 500 Da; (ii) log P is
under 5; (iii) there are less than 5 H-bond donors; (iv) there are
less than 10H-bond acceptors.
NOTE 4: Veber [41] found that reduced molecular flexibility, as
measured by the number of rotatable bonds (NRB), and low
polar surface area (PSA) or total hydrogen bond count (sum of
donors and acceptors) are important predictors of good oral
bioavailability, independent of molecular weight. He suggested
that a high probability of good oral bioavailability is obtained if:
(i) the polar surface area is equal to or less than 140 Å2; (ii) there
are 10 or fewer rotatable bonds.
NOTE 5: LipE¼ pIC50 e log P. It combines both potency and
lipophilicity. It gives an estimation on the binding of a ligand to a
given target. It is suggested to target a LipE in a range of 5e7 or
even higher [43]. There is a greater likelihood of achieving good
in vivo performance when potency can be increased without
increasing logP [42].
NOTE 6: LE is defined as LE¼ 1.4  pIC50/NH, where NH is the
number of heavy atoms. It gives a measure of the properties of
molecules, such as size and lipophilicity, needed to increase
their binding affinity to a drug target [42].
NOTE 7: LELP¼ log P/LE. The optimal LELP scores are10< LELP
<10 [47].
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 Abstract 
دراسة العالقة  غير أن. اكتشاف األدوية عملية تتطلب وقتا و إمكانيات ضخمة من أجل البحث و التطوير: ملخص
تساهم بفعالية  قواعد قابلية االستعمال الدوائي إلىبين خصائص المركبات الكيميائية و نشاطها باإلضافة الكمية 
  .في اقتراح و اكتشاف مركبات فعالة جديدة
تعتبر مضادات األكسدة حاليا من أكثر المواد المدروسة و المستعملة في الصناعات الدوائية و الغذائية نظرا  
 . تثبط الجذور الحرة المسببة لإلجهاد التأكسدي لفعاليتها ضد تأثيرات الشيخوخة، حيث
ي هذا العمل بدراسة العالقة الكمية بين الخصائص الكيميائية و النشاط المضاد قمنا ففي هذا اإلطار، 
 الشبكات العصبية تمت الدراسة بطرقflavonoids. و benzofurans لألكسدة لنوعين من المركبات هما
    0.6.   و فاق قيمة مقبوالمعامل التنبؤ كان . القليلة االستعمال في هذا المجال  Gaussian processو
فابر و ليبينسكي باإلضافة الى معايير الدسامة سمحت بتعيين المركبات  القائمة على قاعد الدوائيقابلية االستعمال       
 .الخاضعة لخصائص األدوية
العالقة الكمية بين الخصائص و النشاط، ، benzofurans ،flavonoidsمضادات األكسدة،  ꞉ الكلمات الجوهرية
  .قابلية االستعمال الدوائي، Gaussian process، الشبكات العصبية
Abstract: Drug discovery takes many years and requires big budgets for research and 
development. QSAR in addition to drug likeness studies contribute strongly to predict and 
discover new active molecules.  
Nowadays, the antioxidants are among the most studied and used molecules in drugs and 
food industries because of their anti-ageing effects. They scavenge free radicals causing 
oxidative stress.  
In this work, we perform a QSAR modeling of the antioxidant activity for two sets of 
benzofurans and flavonoids by artificial neural networks and Gaussian process seldom used in 
this approach. Their predictability coefficient was acceptable with a value that exceeds 0.6. 
Drug likeness studies based on Lipinski and Veber rules, besides the lipophilicity indices 
permitted to define the drug like molecules. 
Keywords: Antioxidants, Benzofurans, Flavonoids, QSAR, ANN, Gaussian process, Drug 
likeness. 
Résumé: La découverte de nouveaux médicaments demande des années et des grands budgets pour la 
recherche et le développement. Néanmoins, QSAR et les études de ressemblance aux 
médicaments contribuent fortement dans la prédiction et la découverte de nouvelles molécules 
actives.  
Les antioxydants sont actuellement parmi les produits les plus étudiés et utilisés dans 
l’industrie pharmaceutique et alimentaire vue leurs effets anti-âge. Ils inhibent les radicaux 
libres qui initient les stress oxydatifs. 
Dans ce travail, on établit des modèles QSAR pour l’activité antioxydante de deux séries 
de benzofuranes et de flavonoïdes par les techniques de réseaux de neurones artificiels et de 
processus gaussien rarement utilisé dans cette approche. Les coefficients de prédiction se 
trouvent acceptables avec une valeur qui dépasse 0.6.    
L’étude de ressemblance aux médicaments, basée sur les règles de Lipinski et Veber ainsi 
que les indices de lipophilicité, a permis de définir les molécules candidates d’être des 
médicaments. 
Mots clés: Antioxydants, Benzofuranes, Flavonoïdes, QSAR, ANN, Processus gaussien, 
Ressemblance aux médicaments. 
